[
  {
    "id": 1,
    "question": "关于人体造血器官的叙述,错误的是",
    "options": ["A.骨髓", "B.胸腺", "C.肝脏", "D.肾脏", "E.淋巴结"],
    "answer": "D"
  },
  {
    "id": 2,
    "question": "卵黄囊造血期起始于人胚发育",
    "options": ["A.第1周", "B.第1周末", "C.第1周末第2周初", "D.第2周", "E.第2周末"],
    "answer": "E"
  },
  {
    "id": 3,
    "question": "在胚胎发育过程中,肝脏作为主要的造血场所,时间为",
    "options": ["A.2~6个月", "B.2~7个月", "C.3~6个月", "D.3~7个月", "E.6~7个月"],
    "answer": "C"
  },
  {
    "id": 4,
    "question": "自胚胎发育第几周,骨髓开始造血",
    "options": ["A.13", "B.14", "C.15", "D.16", "E.17"],
    "answer": "B"
  },
  {
    "id": 5,
    "question": "胚胎期三个造血阶段是",
    "options": ["A.截然分开,前后相继", "B.基本重叠", "C.互相交替,此消彼长", "D.顺序不定", "E.某个阶段可以缺失"],
    "answer": "C"
  },
  {
    "id": 6,
    "question": "在胚胎造血期,骨髓造血的造血细胞大部分来源于",
    "options": ["A.卵黄囊", "B.肝脏", "C.脾脏", "D.淋巴结", "E.胸腺"],
    "answer": "B"
  },
  {
    "id": 7,
    "question": "胚胎造血期所产生的血红蛋白是",
    "options": ["A.Hb-Gower 1", "B.Hb-Gower 2", "C.HbF", "D.HbA", "E.HbA₂"],
    "answer": "C"
  },
  {
    "id": 8,
    "question": "血细胞形成的顺序依次为",
    "options": ["A.红细胞、粒细胞、巨核细胞、淋巴细胞和单核细胞", "B.红细胞、巨核细胞、粒细胞、单核细胞和淋巴细胞", "C.粒细胞、红细胞、巨核细胞、淋巴细胞和单核细胞", "D.粒细胞、红细胞、淋巴细胞、单核细胞和巨核细胞", "E.红细胞、粒细胞、淋巴细胞、巨核细胞和单核细胞"],
    "answer": "A"
  },
  {
    "id": 9,
    "question": "出生后,唯一产生红系、粒系和巨核系细胞的造血器官是",
    "options": ["A.胸腺", "B.脾脏", "C.淋巴结", "D.骨髓", "E.肝脏"],
    "answer": "D"
  },
  {
    "id": 10,
    "question": "关于造血微环境组成的叙述,错误的是",
    "options": ["A.骨髓微血管系统", "B.造血细胞", "C.末梢神经", "D.骨髓基质细胞", "E.骨髓基质细胞分泌的细胞因子"],
    "answer": "B"
  },
  {
    "id": 11,
    "question": "在红骨髓内最突出的结构是",
    "options": ["A.结缔组织", "B.神经", "C.造血细胞", "D.基质细胞", "E.血窦"],
    "answer": "E"
  },
  {
    "id": 12,
    "question": "关于造血干细胞的叙述,错误的是",
    "options": ["A.造血干细胞主要存在于骨髓中", "B.具有高度的自我更新能力", "C.具有多向分化能力且分化方向可逆", "D.膜表面特异性抗原CD34+ CD38-", "E.细胞增殖方式为不对称有丝分裂"],
    "answer": "C"
  },
  {
    "id": 13,
    "question": "关于骨髓中特有细胞的叙述,错误的是",
    "options": ["A.嗜碱性粒细胞", "B.嗜酸性中幼粒细胞", "C.中性晚幼粒细胞", "D.浆细胞", "E.破骨细胞"],
    "answer": "A"
  },
  {
    "id": 14,
    "question": "关于正向调控因子的叙述,错误的是",
    "options": ["A.SCF", "B.IFN-γ", "C.CSF-GM", "D.TPO", "E.PDGF"],
    "answer": "B"
  },
  {
    "id": 15,
    "question": "属于集落刺激因子的是",
    "options": ["A.HGF", "B.IGF", "C.CSF", "D.IL", "E.EPO"],
    "answer": "C"
  },
  {
    "id": 16,
    "question": "关于骨髓间充质干细胞特点的叙述,错误的是",
    "options": ["A.一种成体干细胞", "B.具有自我更新能力及多向分化能力", "C.造血微环境的重要成分", "D.可以向多种组织细胞分化", "E.只存在于骨髓中"],
    "answer": "E"
  },
  {
    "id": 17,
    "question": "可导致肝、脾、淋巴结等组织恢复髓外造血的疾病是",
    "options": ["A.脓毒症", "B.骨髓纤维化", "C.骨髓增生异常综合征", "D.纯红再障", "E.过敏性紫癜"],
    "answer": "B"
  },
  {
    "id": 18,
    "question": "关于早幼粒细胞特点的叙述,错误的是",
    "options": ["A.胞体较原粒大,圆形或椭圆形", "B.常可见核仁", "C.A颗粒和S颗粒可以并存", "D.核质比较大", "E.核染色质比较细致"],
    "answer": "C"
  },
  {
    "id": 19,
    "question": "细胞胞核常居中,核染色质呈块状,副染色质透亮,核仁消失,胞质量较多嗜多色性,推测该细胞为",
    "options": ["A.晚幼红细胞", "B.原始红细胞", "C.浆细胞", "D.中幼红细胞", "E.中幼粒细胞"],
    "answer": "D"
  },
  {
    "id": 20,
    "question": "细胞直径8~15µm;胞核圆形常偏位,核染色质呈块状;胞质丰富,深蓝色不透明,常有泡沫感,推测该细胞为",
    "options": ["A.早幼红细胞", "B.中幼红细胞", "C.晚幼红细胞", "D.浆细胞", "E.小淋巴细胞"],
    "answer": "D"
  },
  {
    "id": 21,
    "question": "成人需要进行骨髓检查时,临床上最理想的穿刺部位是",
    "options": ["A.胸骨", "B.髂骨上棘", "C.肋骨", "D.股骨", "E.胫骨内侧"],
    "answer": "B"
  },
  {
    "id": 22,
    "question": "关于骨髓低倍镜检查的内容的叙述,错误的是",
    "options": ["A.观察细胞形态并计数", "B.判断增生程度", "C.计数巨核细胞", "D.观察有无体积较大的异常细胞", "E.判断骨髓涂片的质量"],
    "answer": "A"
  },
  {
    "id": 23,
    "question": "关于骨髓象有核细胞计数分类所针对的细胞的叙述,错误的是",
    "options": ["A.原始细胞", "B.退化细胞", "C.组织细胞", "D.吞噬细胞", "E.成骨细胞"],
    "answer": "B"
  },
  {
    "id": 24,
    "question": "关于判断骨髓涂片质量好坏的叙述,错误的是",
    "options": ["A.涂片厚薄", "B.骨髓小粒多少", "C.染色时间", "D.血小板数量", "E.染色酸碱度"],
    "answer": "D"
  },
  {
    "id": 25,
    "question": "健康成人骨髓象粒红比值大约在",
    "options": ["A.1:1", "B.(1~2):1", "C.(2~4):1", "D.(4~6):1", "E.(1:2)~4"],
    "answer": "C"
  },
  {
    "id": 26,
    "question": "关于正常骨髓象特点的叙述,错误的是",
    "options": ["A.红细胞系统占15%~25%", "B.原始粒细胞<2%", "C.早幼红细胞<5%", "D.单核细胞系统<4%", "E.浆细胞<8%"],
    "answer": "E"
  },
  {
    "id": 27,
    "question": "关于骨髓象检验注意事项的叙述,错误的是",
    "options": ["A.介于两阶段之间的细胞应归入下一发育阶段", "B.介于两系统之间的,可以采用大数归类法", "C.要抓住细胞的一两个特点进行鉴别", "D.结合细胞化学染色", "E.难以鉴别的细胞,可划为分类不明细胞,但应动态观察"],
    "answer": "C"
  },
  {
    "id": 28,
    "question": "骨髓内不具有吞噬功能的细胞是",
    "options": ["A.单核细胞", "B.内皮细胞", "C.组织细胞", "D.纤维细胞", "E.涂抹细胞"],
    "answer": "E"
  },
  {
    "id": 29,
    "question": "两种疾病骨髓象有区别而血象相似的是",
    "options": ["A.溶血性贫血与急性失血", "B.神经母细胞瘤骨髓转移与急性粒细胞白血病", "C.传染性淋巴细胞增多症和慢性淋巴细胞白血病", "D.传染性单核细胞增多症和急性淋巴细胞白血病", "E.遗传性球形红细胞增多症和遗传性椭圆形红细胞增多症"],
    "answer": "A"
  },
  {
    "id": 30,
    "question": "细胞形态学改变为核染色质浓聚、固缩,聚集在核膜周边,细胞核裂解成若干碎片,细胞膜将胞质和染色质断片包裹,形成多个膜结构尚完整的泡状小体,此种细胞形态学改变是",
    "options": ["A.细胞坏死的特征", "B.细胞凋亡的特征", "C.细胞自噬的特征", "D.细胞焦亡的特征", "E.细胞增殖的特征"],
    "answer": "B"
  },
  {
    "id": 31,
    "question": "关于自噬的叙述,错误的是",
    "options": ["A.形态学方法检测自噬的金标准是电镜检查", "B.LC3是目前检测自噬的主要标志蛋白", "C.胞质中可出现大量双膜自噬体", "D.mTOR 基因是自噬启动阶段的关键调节基因", "E.对不同种类的细胞自噬的作用相同"],
    "answer": "E"
  },
  {
    "id": 32,
    "question": "哺乳动物参与自噬的特异性基因是",
    "options": ["A.P53 基因", "B.WT1基因", "C.Beclin-1基因", "D.bcl-2基因", "E.ras 基因"],
    "answer": "C"
  },
  {
    "id": 33,
    "question": "关于促进细胞增殖和存活的基因的叙述,错误的是",
    "options": ["A.c-myc 基因", "B.c-abl 基因", "C.ras 基因", "D.P53 基因", "E.bcl-2基因"],
    "answer": "D"
  },
  {
    "id": 34,
    "question": "最适宜用于鉴别急性淋巴细胞白血病和急性粒细胞白血病的细胞化学染色是",
    "options": ["A.髓过氧化物酶染色", "B.碱性磷酸酶染色", "C.过碘酸希夫反应", "D.酯酶染色", "E.酸性磷酸酶染色"],
    "answer": "A"
  },
  {
    "id": 35,
    "question": "细胞化学染色复染的目的是",
    "options": ["A.保持细胞结构及化学成分的不变", "B.使各种细胞能显示出来便于辨认", "C.与细胞内特定成分反应,形成沉淀", "D.改变细胞结构", "E.改变细胞内的化学成分"],
    "answer": "B"
  },
  {
    "id": 36,
    "question": "骨髓中细胞外铁主要存在于",
    "options": ["A.骨髓小粒的巨噬细胞", "B.中幼红细胞", "C.晚幼红细胞", "D.成骨细胞", "E.破骨细胞"],
    "answer": "A"
  },
  {
    "id": 37,
    "question": "正常情况下,骨髓铁染色细胞外铁和内铁为",
    "options": ["A.细胞外铁(+)~(++),铁粒幼红细胞阳性率在12%~44%", "B.细胞外铁(++)~(+++),铁粒幼红细胞阳性率在12%~44%", "C.细胞外铁(+)~(++),环铁粒幼红细胞阳性率大于15%", "D.细胞外铁(++)~(+++),环铁粒幼红细胞阳性率小于15%", "E.细胞外铁(++)~(+++),环铁粒幼红细胞阳性率小于5%"],
    "answer": "A"
  },
  {
    "id": 38,
    "question": "关于铁染色临床意义的叙述,错误的是",
    "options": ["A.缺铁性贫血细胞内外铁都减少", "B.铁粒幼细胞贫血细胞内外铁都增多", "C.感染引起的贫血细胞外铁减小", "D.再生障碍性贫血细胞内外铁都正常或增加", "E.溶血性贫血细胞内外铁都正常或增加"],
    "answer": "C"
  },
  {
    "id": 39,
    "question": "中性粒细胞碱性磷酸酶主要存在于",
    "options": ["A.原始粒细胞和早幼粒细胞", "B.中性中幼粒细胞和晚幼粒细胞", "C.中性晚幼粒细胞和杆状核粒细胞", "D.中性杆状核粒细胞和分叶核粒细胞", "E.中性分叶核粒细胞和单核细胞"],
    "answer": "D"
  },
  {
    "id": 40,
    "question": "关于中性粒细胞碱性磷酸酶染色临床意义的叙述,错误的是",
    "options": ["A.细菌性感染,酶活性增高", "B.类白血病反应,酶活性增高", "C.再生障碍性贫血,酶活性增高", "D.阵发性睡眠性血红蛋白尿症,酶活性降低", "E.慢性髓细胞白血病急变期,酶活性降低"],
    "answer": "E"
  },
  {
    "id": 41,
    "question": "关于髓过氧化物酶染色结果的叙述,错误的是",
    "options": ["A.淋巴细胞系统的细胞呈阴性", "B.单核细胞系统的细胞呈阴性或弱阳性", "C.嗜酸性粒细胞强阳性", "D.各期中性粒细胞均可阳性", "E.巨核细胞和有核红细胞呈阳性"],
    "answer": "E"
  },
  {
    "id": 42,
    "question": "关于髓过氧化物酶染色的叙述,错误的是",
    "options": ["A.可以用陈旧性标本染色", "B.反应底物不同沉淀颜色可出现不同", "C.急性淋巴细胞白血病髓过氧化物酶染色的阳性率<3%", "D.涂片中成熟中性粒细胞呈强阳性,即可排除试剂失效", "E.可用瑞氏染液作为复染液"],
    "answer": "A"
  },
  {
    "id": 43,
    "question": "辅助判断急性白血病细胞类型的首选的、最重要的细胞化学染色是",
    "options": ["A.酸性磷酸酶染色", "B.髓过氧化物酶染色", "C.中性粒细胞碱性磷酸酶染色", "D.非特异性酯酶染色加氟化钠抑制试验", "E.特异性酯酶染色"],
    "answer": "B"
  },
  {
    "id": 44,
    "question": "在诊断恶性红细胞系统疾病中最有价值的细胞化学染色是",
    "options": ["A.髓过氧化物酶染色", "B.过碘酸希夫反应", "C.酸性磷酸酶染色", "D.酯酶染色", "E.碱性磷酸酶染色"],
    "answer": "B"
  },
  {
    "id": 45,
    "question": "关于过碘酸希夫反应的叙述,错误的是",
    "options": ["A.阳性反应的本质是细胞含有乙二醇基的多糖类物质", "B.随着中性粒细胞的成熟阳性程度逐渐增强", "C.能辅助鉴别良恶性淋巴细胞疾病", "D.戈谢细胞呈强阳性", "E.能有效地鉴别红血病和急性巨核细胞白血病"],
    "answer": "E"
  },
  {
    "id": 46,
    "question": "被称为粒细胞酯酶的是",
    "options": ["A.α 醋酸萘酚酯酶染色", "B.α 丁酸萘酚酯酶染色", "C.醋酸AS-D萘酚酯酶染色", "D.氯乙酸AS-D萘酚酯酶染色", "E.酸性醋酸萘酚酯酶染色"],
    "answer": "D"
  },
  {
    "id": 47,
    "question": "酯酶双染色对诊断疾病具有重要意义的是",
    "options": ["A.急性早幼粒细胞白血病", "B.急性髓系白血病伴成熟型", "C.急性单核细胞白血病", "D.急性粒-单核细胞白血病", "E.骨髓增生异常综合征"],
    "answer": "D"
  },
  {
    "id": 48,
    "question": "鉴别多毛细胞白血病与慢性淋巴细胞白血病首选的细胞化学染色是",
    "options": ["A.髓过氧化物酶染色", "B.非特异性酯酶加氟化钠抑制", "C.中性粒细胞碱性磷酸酶染色", "D.酸性磷酸酶染色", "E.过碘酸希夫反应"],
    "answer": "D"
  },
  {
    "id": 49,
    "question": "急性粒细胞白血病与急性单核白血病的主要鉴别要点是",
    "options": ["A.骨髓中 Auer 小体的有无", "B.髓过氧化物酶染色阳性率", "C.过碘酸希夫反应的阳性程度", "D.非特异性酯酶染色阳性可否被氟化钠抑制", "E.中性粒细胞碱性磷酸酶染色阳性率"],
    "answer": "D"
  },
  {
    "id": 50,
    "question": "最有必要做骨髓活检的疾病是",
    "options": ["A.缺铁性贫血", "B.慢性淋巴细胞白血病", "C.骨髓纤维化", "D.类白血病反应", "E.溶血性贫血"],
    "answer": "C"
  },
  {
    "id": 51,
    "question": "关于造血细胞培养作用和意义的叙述,错误的是",
    "options": ["A.研究药物对骨髓造血的影响", "B.研究造血系统疾病的发生机制、诊断和治疗效果分析", "C.研究各种细胞因子对造血调节的作用机制", "D.研究造血过程造血细胞分化、成熟及其调节机制", "E.分析造血细胞分化抗原的表达水平"],
    "answer": "E"
  },
  {
    "id": 52,
    "question": "关于血液分子生物学检验技术内容的叙述,错误的是",
    "options": ["A.染色体显带技术", "B.核酸分子杂交技术", "C.聚合酶链反应技术", "D.基因芯片技术", "E.miRNA表达谱分析技术"],
    "answer": "A"
  },
  {
    "id": 53,
    "question": "巨核细胞系的免疫表型特征是",
    "options": ["A.MPO、CD13、CD33均阴性", "B.CD19、CD20均阳性", "C.CD11c、CD14、CD64均阳性", "D.CD3、CD4强阳性", "E.CD41、CD61 阳性"],
    "answer": "E"
  },
  {
    "id": 54,
    "question": "9号染色体长臂,3区4带的第1亚带染色体位点,表达正确的是",
    "options": ["A.9p3.4.1", "B.9p34.1", "C.9q3.4.1", "D.9q34.1", "E.9q3.41"],
    "answer": "D"
  },
  {
    "id": 55,
    "question": "某研究员在做人工诱导干细胞向血管内皮细胞分化的时候,应特别注意观察胞质内的结构是",
    "options": ["A.棒杆状小体(W-P小体)", "B.Auer 小体", "C.线粒体", "D.高尔基复合体", "E.核糖体"],
    "answer": "A"
  },
  {
    "id": 56,
    "question": "关于血管壁的止血功能的叙述,错误的是",
    "options": ["A.血管收缩增强", "B.激活血小板", "C.促进血液凝固", "D.合成和释放前列环素增多", "E.分泌入血的纤溶酶原活化抑制剂增多"],
    "answer": "D"
  },
  {
    "id": 57,
    "question": "可作为血管内皮损伤的分子标志物是",
    "options": ["A.β血小板球蛋白", "B.内皮素和血栓调节蛋白", "C.血小板第4因子", "D.血管升压素", "E.血栓烷 B₂"],
    "answer": "B"
  },
  {
    "id": 58,
    "question": "关于血管促进血液凝固的叙述,错误的是",
    "options": ["A.胶原成分暴露启动内源凝血", "B.内皮细胞释放大量的TF启动外源凝血", "C.Ca²+ 可自由进出,调节血液凝固的速度", "D.合成和释放 t-PA增多,调节纤维蛋白溶解", "E.内皮细胞上有一些凝血因子的结合部位,使凝血发生局限于内膜表面"],
    "answer": "D"
  },
  {
    "id": 59,
    "question": "血小板的膜糖蛋白中,可作为vWF受体的是",
    "options": ["A.GP Ib/IX", "B.GP IIb/IIIa", "C.GP IV", "D.GP Ia/IIa", "E.GPVI"],
    "answer": "A"
  },
  {
    "id": 60,
    "question": "参与血小板聚集且是Fg受体的血小板膜糖蛋白是",
    "options": ["A.GP Ib/IX", "B.GP IIb/IIIa", "C.GPIV", "D.GP Ia/IIa", "E.GPVI"],
    "answer": "B"
  },
  {
    "id": 61,
    "question": "血小板黏附率增高见于",
    "options": ["A.脑梗死", "B.血管性血友病", "C.急性白血病", "D.巨大血小板综合征", "E.肝硬化"],
    "answer": "A"
  },
  {
    "id": 62,
    "question": "关于凝血酶敏感的凝血因子的叙述,错误的是",
    "options": ["A.FI", "B.FV", "C.FVI", "D.FVIII", "E.FXIII"],
    "answer": "C"
  },
  {
    "id": 63,
    "question": "参与凝血活酶形成的凝血因子是",
    "options": ["A.FIX", "B.FX", "C.FVII", "D.FVI", "E.FIII"],
    "answer": "B"
  },
  {
    "id": 64,
    "question": "含有凝血因子V和VIII的血液成分是",
    "options": ["A.新鲜的硫酸钡吸附血清", "B.正常人新鲜血清", "C.正常人新鲜血浆", "D.贮存的硫酸钡吸附血清", "E.贮存的硫酸钡吸附血浆"],
    "answer": "C"
  },
  {
    "id": 65,
    "question": "关于凝血因子的叙述,正确的是",
    "options": ["A.正常血清中不含FV和FVIII", "B.新鲜血浆含有各种凝血因子", "C.正吸浆中主要含有FVII、FXI、FXII", "D.正吸清中主要有FIX、FV、FVIII", "E.正常血清主要含有FVII、FIX、FXI、FXII"],
    "answer": "A"
  },
  {
    "id": 66,
    "question": "活化蛋白C能灭活的凝血因子是",
    "options": ["A.FVIIa、FXa", "B.FXIa、FIXa", "C.FVa、FVIIIa", "D.AT-III和肝素辅因子", "E.FXIIa、FXIIIa"],
    "answer": "C"
  },
  {
    "id": 67,
    "question": "参与血液凝固的物质是",
    "options": ["A.纤溶酶", "B.抗凝血酶", "C.蛋白C", "D.组织因子", "E.纤溶酶原激活抑制物"],
    "answer": "D"
  },
  {
    "id": 68,
    "question": "血浆中最重要的一种生理性抗凝物质是",
    "options": ["A.抗凝血酶III", "B.蛋白Z", "C.蛋白C", "D.蛋白S", "E.纤维蛋白溶解酶"],
    "answer": "A"
  },
  {
    "id": 69,
    "question": "属于交联纤维蛋白降解产物的是",
    "options": ["A.碎片X", "B.碎片Y", "C.碎片E", "D.D-二聚体", "E.碎片 D'"],
    "answer": "D"
  },
  {
    "id": 70,
    "question": "关于PAI-1主要作用的叙述,错误的是",
    "options": ["A.有效灭活 t-PA", "B.不能有效抑制 u-PA", "C.能抑制凝血酶的活性", "D.能抑制FXa的活性", "E.能抑制活化蛋白C的活性"],
    "answer": "B"
  },
  {
    "id": 71,
    "question": "可通过外激活途径激活纤维蛋白溶解酶原的物质是",
    "options": ["A.FXII", "B.t-PA", "C.TM", "D.肝素", "E.枸橼酸盐"],
    "answer": "B"
  },
  {
    "id": 72,
    "question": "进行出血和凝血检验,常用的抗凝剂是",
    "options": ["A.EDTA 盐", "B.草酸钾", "C.草酸铵", "D.肝素", "E.枸橼酸钠"],
    "answer": "E"
  },
  {
    "id": 73,
    "question": "凝血酶时间(TT)延长,可能有缺陷的凝血因子是",
    "options": ["A.因子I", "B.因子II", "C.因子III", "D.因子V", "E.因子VII"],
    "answer": "A"
  },
  {
    "id": 74,
    "question": "常用于检测内源性凝血系统异常的筛选试验是",
    "options": ["A.PT", "B.APTT", "C.PF3有效性测定", "D.D-二聚体检测", "E.束臂试验"],
    "answer": "B"
  },
  {
    "id": 75,
    "question": "可用来筛选凝血因子异常和抗凝物质增多的试验是",
    "options": ["A.PT、APTT、PLT", "B.PT、APTT、PAgT", "C.PT、APTT、BT", "D.PT、APTT、TT", "E.PT、APTT、STGT"],
    "answer": "D"
  },
  {
    "id": 76,
    "question": "有明显加强AT-III抗凝作用的是",
    "options": ["A.肝素", "B.纤溶酶", "C.凝血酶", "D.蛋白C", "E.蛋白S"],
    "answer": "A"
  },
  {
    "id": 77,
    "question": "反映纤溶活性增强的筛选试验是",
    "options": ["A.复钙交叉试验", "B.凝血酶时间测定", "C.优球蛋白溶解试验", "D.试管法凝血时间测定", "E.血浆硫酸鱼精蛋白副凝固试验"],
    "answer": "C"
  },
  {
    "id": 78,
    "question": "外源凝血系统最常用的筛选试验是",
    "options": ["A.APTT", "B.PT", "C.TT", "D.纤维蛋白原测定", "E.3P 试验"],
    "answer": "B"
  },
  {
    "id": 79,
    "question": "关于免疫性血小板减少症的叙述,错误的是",
    "options": ["A.血小板无效生成", "B.血涂片和骨髓片上血小板散在少见", "C.骨髓片上巨核细胞缺如", "D.血小板抗体增高", "E.血小板寿命缩短"],
    "answer": "C"
  },
  {
    "id": 80,
    "question": "组织因子途径抑制物(TFPI)调节TF-FVIIa参与凝血的过程中",
    "options": ["A.不需要Ca2+的参与", "B.TFPI促进血液凝固", "C.TFPI可以直接抑制因子VIIa的活性", "D.TFPI可以直接抑制因子Xa的活性", "E.直接与血液中存在病理性循环抗凝物质结合"],
    "answer": "D"
  },
  {
    "id": 81,
    "question": "关于纤维蛋白降解产物(FDP)生理功能的叙述,正确的是",
    "options": ["A.促进血小板聚集", "B.抑制血液凝固", "C.促进纤维蛋白溶解", "D.抑制抗凝血系统", "E.促进血管收缩"],
    "answer": "B"
  },
  {
    "id": 82,
    "question": "用于检测可溶性纤维蛋白单体的试验是",
    "options": ["A.3P 试验", "B.ELT", "C.TT", "D.束臂试验", "E.STGT"],
    "answer": "A"
  },
  {
    "id": 83,
    "question": "关于纤维蛋白(原)降解产物的叙述,正确的是",
    "options": ["A.纤维蛋白原的降解产物有碎片X、Y、Bβ1-14等", "B.Fb-II的降解产物主要是 Aα16-42", "C.Fb 的降解产物主要有D-二聚体、DD-二聚体、碎片E", "D.纤维蛋白(原)降解产物起抗凝作用", "E.Fb-I的降解产物主要是 Bβ15-42、碎片 D'"],
    "answer": "D"
  },
  {
    "id": 84,
    "question": "关于急性ITP临床表现的叙述,正确的是",
    "options": ["A.皮肤黏膜出血较严重", "B.多见于女性", "C.多见于成人", "D.常有肝脾大", "E.病程一般在半年以上"],
    "answer": "A"
  },
  {
    "id": 85,
    "question": "关于血友病的叙述,错误的是",
    "options": ["A.出血部位以关节和肌肉为主", "B.APTT 延长", "C.PT不延长", "D.凝血因子VIII、IX缺乏", "E.只因为缺陷因子VIII"],
    "answer": "E"
  },
  {
    "id": 86,
    "question": "关于过敏性紫癜的叙述,正确的是",
    "options": ["A.患者的首发症状是皮肤瘙痒", "B.是由于遗传因素导致的凝血因子异常引起的疾病", "C.是一种毛细血管变态反应性出血性疾病", "D.患者血小板计数明显减低", "E.血清IgA升高为特异性实验室检验项目"],
    "answer": "C"
  },
  {
    "id": 87,
    "question": "关于DIC的叙述,错误的是",
    "options": ["A.血管内有微血栓形成", "B.PT可延长", "C.APTT可缩短", "D.D-二聚体检测结果始终阴性", "E.3P试验可阳性"],
    "answer": "D"
  },
  {
    "id": 88,
    "question": "关于出血性疾病的叙述,错误的是",
    "options": ["A.血管性紫癜是一种以胃肠道、鼻出血为主的出血性疾病", "B.ITP 患者血小板减少、PAIg和PAC3 增高", "C.DIC 始于凝血系统的被激活", "D.因子缺乏症APTT和PT均正常", "E.出血性疾病表现为自发性或轻微外伤后出血难止"],
    "answer": "A"
  },
  {
    "id": 89,
    "question": "诊断温抗体型自身免疫性溶血性贫血最重要的实验室检查是",
    "options": ["A.Ham 试验", "B.Coombs 试验", "C.Donath-Landsteiner 试验", "D.免疫球蛋白测定", "E.血红蛋白电泳"],
    "answer": "B"
  },
  {
    "id": 90,
    "question": "关于血管内溶血直接证据的叙述,正确的是",
    "options": ["A.外周血网织红细胞计数增高", "B.血液直接胆红素增高", "C.血浆游离血红蛋白显著增高", "D.异形红细胞多见", "E.骨髓有核细胞增生明显活跃"],
    "answer": "C"
  },
  {
    "id": 91,
    "question": "属于红细胞破坏过度直接证据的是",
    "options": ["A.血浆中出现高铁血红素白蛋白复合物", "B.血清结合珠蛋白水平显著升高", "C.Coombs 试验阳性", "D.网织红细胞计数升高", "E.骨髓红系明显增生活跃"],
    "answer": "A"
  },
  {
    "id": 92,
    "question": "血管内溶血的特点是",
    "options": ["A.遗传性多见", "B.红细胞在单核-巨噬细胞系统破坏", "C.破碎红细胞易见", "D.Rous 试验一定阳性", "E.血清结合珠蛋白明显升高"],
    "answer": "C"
  },
  {
    "id": 93,
    "question": "属于血管内溶血的疾病是",
    "options": ["A.阵发性睡眠性血红蛋白尿症", "B.β-珠蛋白生成障碍性贫血", "C.α-珠蛋白生成障碍性贫血", "D.温抗体型自身免疫性溶血性贫血", "E.遗传性球形红细胞增多症"],
    "answer": "A"
  },
  {
    "id": 94,
    "question": "卟啉病的发生机制是",
    "options": ["A.珠蛋白合成不足", "B.血红素合成中酶缺陷", "C.珠蛋白一级结构异常", "D.红细胞核苷酸代谢异常", "E.铁代谢异常"],
    "answer": "B"
  },
  {
    "id": 95,
    "question": "关于阵发性睡眠性血红蛋白尿症的叙述,正确的是",
    "options": ["A.是一种遗传性血细胞膜缺陷性疾病,可表现为全血细胞减少", "B.贫血为大细胞正色素性或低色素性,网织红细胞多为降低", "C.常以酸化血清溶血试验作为其筛选试验,而确诊主要靠蔗糖溶血试验", "D.可出现CD59 表达缺陷细胞群", "E.骨髓象中可见血细胞出现病态变化"],
    "answer": "D"
  },
  {
    "id": 96,
    "question": "有助于降低血红蛋白对氧亲和力的红细胞内代谢过程是",
    "options": ["A.磷酸戊糖途径", "B.糖酵解", "C.2,3-二磷酸甘油酸支路", "D.铁代谢", "E.核苷酸代谢"],
    "answer": "C"
  },
  {
    "id": 97,
    "question": "末梢血反映骨髓红细胞系增生程度最准确的指标是",
    "options": ["A.血红蛋白与红细胞计数", "B.网织红细胞百分率", "C.网织红细胞绝对值", "D.出现有核红细胞", "E.红细胞内出现豪-乔小体"],
    "answer": "C"
  },
  {
    "id": 98,
    "question": "关于珠蛋白生成障碍性贫血的叙述,正确的是",
    "options": ["A.主要由于珠蛋白的氨基酸序列改变而引起血红蛋白功能异常", "B.红细胞渗透脆性往往增高", "C.HbA2>3.9%提示可能为α-珠蛋白生成障碍性贫血", "D.HbH病是β-珠蛋白生成障碍性贫血的一个亚型", "E.Hb Barts 病时,由于缺失4个基因,无α链生成,而形成Hb Barts (γ4)"],
    "answer": "E"
  },
  {
    "id": 99,
    "question": "关于各种溶血性疾病及相关检测的叙述,正确的是",
    "options": ["A.Coombs 试验阴性可排除免疫性溶血性贫血的诊断", "B.间接抗球蛋白试验主要检测患者血清中有无游离抗体或补体,诊断价值高于直接抗球蛋白试验", "C.阵发性寒冷性血红蛋白尿症患者的溶血主要发生在血管外", "D.冷凝集素是一种IgG冷反应性抗体", "E.阵发性睡眠性血红蛋白尿症可由再生障碍性贫血转化而来,也可演变成再生障碍性贫血,或两者同时存在"],
    "answer": "E"
  },
  {
    "id": 100,
    "question": "属于血管内溶血实验室特点的是",
    "options": ["A.血清结合珠蛋白增高", "B.血浆游离血红蛋白显著升高", "C.红细胞 HbH包涵体阳性", "D.尿胆原阴性", "E.外周血中可见较多异形红细胞"],
    "answer": "B"
  },
  {
    "id": 101,
    "question": "可用于诊断获得性红细胞膜缺陷性溶血性贫血的检查是",
    "options": ["A.红细胞渗透脆性试验", "B.酸化甘油溶血试验", "C.高铁血红蛋白还原试验", "D.血细胞 CD55、CD59表达情况", "E.红细胞膜蛋白SDS-PAGE 电泳"],
    "answer": "D"
  },
  {
    "id": 102,
    "question": "胎儿血红蛋白的肽链组成是",
    "options": ["A.α2γ2", "B.α2β2", "C.αδε", "D.Ba", "E.γ4"],
    "answer": "A"
  },
  {
    "id": 103,
    "question": "诊断自身免疫性溶血性贫血,最没必要做的实验室检查是",
    "options": ["A.D-L抗体测定", "B.冷凝集素测定", "C.Coombs 试验", "D.Heinz 小体生成试验", "E.网织红细胞计数"],
    "answer": "D"
  },
  {
    "id": 104,
    "question": "关于冷凝集素和冷凝集素病的叙述,正确的是",
    "options": ["A.正常人血清中不存在冷凝集素", "B.冷凝集素主要对红细胞的P血型抗原起反应", "C.异常冷凝集素具有低效价低热幅度的特点", "D.冷凝集素病患者的发绀症状会随着温度的回升而消失", "E.对冷凝集素病患者,用单抗IgM 的直接抗球蛋白试验可以为阳性"],
    "answer": "D"
  },
  {
    "id": 105,
    "question": "关于温抗体型自身免疫性溶血性贫血(WAIHA)的叙述,正确的是",
    "options": ["A.WAIHA 患者红细胞仅为补体C3致敏时,会发生严重的溶血", "B.WAIHA 患者外周血中可见较多球形红细胞", "C.抗球蛋白试验阴性可以排除 WAIHA 的诊断", "D.WAIHA 患者用肾上腺皮质激素治疗多数无效", "E.WAIHA 缓解患者,可以伴有抗球蛋白试验的持续阳性"],
    "answer": "B"
  },
  {
    "id": 106,
    "question": "关于反映骨髓红细胞系统代偿性增生的指标的叙述,错误的是",
    "options": ["A.血浆游离血红蛋白增加", "B.骨髓中红系明显增生", "C.外周血可见幼红细胞", "D.血象中嗜多色性红细胞易见", "E.骨髓象中红系分裂象细胞易见"],
    "answer": "A"
  },
  {
    "id": 107,
    "question": "成年男性血红蛋白95g/L,该情况属于",
    "options": ["A.正常", "B.轻度贫血", "C.中度贫血", "D.重度贫血", "E.极重度贫血"],
    "answer": "C"
  },
  {
    "id": 108,
    "question": "关于溶血性贫血的叙述,正确的是",
    "options": ["A.红细胞内在缺陷所致的溶血性贫血多为遗传性", "B.溶血性贫血都属于大细胞性贫血", "C.靶形红细胞增多是珠蛋白生成障碍性贫血特异性的血象特点", "D.HbH可出现在重型珠蛋白生成障碍性贫血患者红细胞中", "E.阵发性睡眠性血红蛋白尿症患者常出现血管外溶血"],
    "answer": "A"
  },
  {
    "id": 109,
    "question": "用于筛查遗传性红细胞膜缺陷与否的试验是",
    "options": ["A.异丙醇沉淀试验", "B.红细胞包涵体试验", "C.高铁血红蛋白还原试验", "D.冷热溶血试验", "E.红细胞渗透脆性试验"],
    "answer": "E"
  },
  {
    "id": 110,
    "question": "关于血红蛋白及其异常的叙述,正确的是",
    "options": ["A.HbA2 是胎儿期主要的血红蛋白", "B.HbA 的肽链构成为α2γ2", "C.珠蛋白肽链的一级结构发生改变,即珠蛋白生成障碍性贫血", "D.β-珠蛋白生成障碍性贫血时HbF可显著增高", "E.重型β-珠蛋白生成障碍性贫血血象呈正常细胞正色素性"],
    "answer": "D"
  },
  {
    "id": 111,
    "question": "属于遗传性红细胞膜缺陷性疾病的是",
    "options": ["A.阵发性睡眠性血红蛋白尿症", "B.β-珠蛋白生成障碍性贫血", "C.蚕豆病", "D.遗传性球形红细胞增多症", "E.卟啉病"],
    "answer": "D"
  },
  {
    "id": 112,
    "question": "判断贫血的指标是",
    "options": ["A.RBC、HCT、MCH", "B.RBC、Hb、HCT", "C.RDW、Hb、MCH", "D.RBC、Hb、MCHC", "E.RDW、MCV、MCHC"],
    "answer": "B"
  },
  {
    "id": 113,
    "question": "碱性缓冲液醋酸纤维膜电泳中,泳动速度最快的正常血红蛋白是",
    "options": ["A.HbA", "B.HbF", "C.HbA2", "D.HbH", "E.HbS"],
    "answer": "A"
  },
  {
    "id": 114,
    "question": "关于红细胞生理学的叙述,正确的是",
    "options": ["A.红细胞在体内破坏的场所主要在骨髓", "B.雌激素可促进红细胞的生成", "C.红细胞膜上的阴离子通道即收缩蛋白", "D.正常人血红蛋白中以 HbA2 占绝大多数", "E.红细胞膜骨架蛋白对维持红细胞形态及功能至关重要"],
    "answer": "E"
  },
  {
    "id": 115,
    "question": "关于引起血管内溶血的疾病的叙述,错误的是",
    "options": ["A.G-6-PD缺乏症", "B.疟疾", "C.PNH", "D.温抗体型自身免疫性溶血性贫血", "E.阵发性冷性血红蛋白尿症"],
    "answer": "D"
  },
  {
    "id": 116,
    "question": "与PNH诊断有关的实验室检查是",
    "options": ["A.碱变性试验", "B.Rous 试验", "C.Coombs 试验", "D.D-L抗体测定", "E.Flaer 测定"],
    "answer": "E"
  },
  {
    "id": 117,
    "question": "珠蛋白生成障碍性贫血的铁代谢特点是",
    "options": ["A.血清铁下降", "B.骨髓铁染色外铁常增加", "C.总铁结合力升高", "D.血清铁蛋白降低", "E.转铁蛋白受体减少"],
    "answer": "B"
  },
  {
    "id": 118,
    "question": "血象中最可能出现较多靶形红细胞的疾病是",
    "options": ["A.MDS", "B.再生障碍性贫血", "C.自身免疫性溶血性贫血", "D.珠蛋白生成障碍性贫血", "E.骨髓纤维化"],
    "answer": "D"
  },
  {
    "id": 119,
    "question": "G-6-PD缺乏症的确诊试验是",
    "options": ["A.高铁血红蛋白还原试验", "B.荧光斑点试验", "C.硝基四氮唑蓝纸片法", "D.Heinz 包涵体试验", "E.G-6-PD活性测定"],
    "answer": "E"
  },
  {
    "id": 120,
    "question": "关于溶血性贫血及其相关检查的组合,错误的是",
    "options": ["A.自身免疫性溶血性贫血———Coombs 试验", "B.PNH-Ham 试验", "C.遗传性球形细胞增多症—红细胞膜蛋白电泳", "D.珠蛋白生成障碍性贫血—血红蛋白电泳", "E.蚕豆病——Rous 试验"],
    "answer": "E"
  },
  {
    "id": 121,
    "question": "关于β-珠蛋白生成障碍性贫血实验室特征的叙述,错误的是",
    "options": ["A.血清结合珠蛋白减少", "B.红细胞渗透脆性增高", "C.HbF升高", "D.末梢血中出现晚幼红细胞", "E.HbA2升高"],
    "answer": "B"
  },
  {
    "id": 122,
    "question": "最不可能出现在溶血性贫血时的检查结果是",
    "options": ["A.血清结合珠蛋白增高", "B.网织红细胞增高", "C.血浆游离血红蛋白增高", "D.末梢血中出现晚幼红细胞", "E.脾大"],
    "answer": "A"
  },
  {
    "id": 123,
    "question": "红细胞内最不可能检测到包涵体的疾病是",
    "options": ["A.β-珠蛋白生成障碍性贫血", "B.α-珠蛋白生成障碍性贫血", "C.G-6-PD缺乏症", "D.不稳定血红蛋白病", "E.遗传性球形细胞增多症"],
    "answer": "E"
  },
  {
    "id": 124,
    "question": "关于溶血性贫血病因学分类的叙述,错误的是",
    "options": ["A.膜缺陷性溶血性贫血", "B.血红蛋白病", "C.酶缺陷性溶血性贫血", "D.血管内溶血性贫血", "E.免疫性溶血性贫血"],
    "answer": "D"
  },
  {
    "id": 125,
    "question": "关于红细胞膜的功能的叙述,错误的是",
    "options": ["A.维持红细胞正常结构和变形能力", "B.进行离子的运输", "C.气体的运输", "D.葡萄糖和水的转运", "E.存在激素和递质类受体参与细胞代谢调节"],
    "answer": "C"
  },
  {
    "id": 126,
    "question": "关于诊断蚕豆病检查的叙述,错误的是",
    "options": ["A.高铁血红蛋白还原试验", "B.变性珠蛋白小体试验", "C.G-6-PD荧光斑点试验", "D.酸化甘油溶血试验", "E.G-6-PD活性检测"],
    "answer": "D"
  },
  {
    "id": 127,
    "question": "与溶血无关的实验室检查结果是",
    "options": ["A.网织红细胞增多", "B.血清直接胆红素水平升高", "C.粪胆原增多", "D.外周血出现破碎红细胞", "E.尿胆原增多"],
    "answer": "B"
  },
  {
    "id": 128,
    "question": "关于PNH的叙述,错误的是",
    "options": ["A.血细胞 CD55、CD59表达下降", "B.反复发作者尿中可检测到含铁血黄素", "C.引起红细胞减少,但中性粒细胞和血小板正常", "D.观察患者血液在轻度酸性时的溶血情况有助于诊断", "E.重症病例可有血栓形成"],
    "answer": "C"
  },
  {
    "id": 129,
    "question": "关于温抗体型自身免疫性溶血性贫血的叙述,错误的是",
    "options": ["A.抗体多为IgG型", "B.有原发性和继发性两型", "C.溶血不一定要补体参加", "D.在血管内引起凝集和溶血", "E.慢性型伴血小板减少即为Evans 综合征"],
    "answer": "D"
  },
  {
    "id": 130,
    "question": "关于红细胞生成减少所致贫血的叙述,错误的是",
    "options": ["A.红细胞酶缺陷性贫血", "B.营养性巨幼细胞贫血", "C.再生障碍性贫血", "D.骨髓病性贫血", "E.缺铁性贫血"],
    "answer": "A"
  },
  {
    "id": 131,
    "question": "体内的铁主要分布在",
    "options": ["A.血红蛋白", "B.铁蛋白及含铁血黄素(贮存铁)", "C.肌红蛋白", "D.转铁蛋白", "E.其他组织中铁(各种酶)"],
    "answer": "A"
  },
  {
    "id": 132,
    "question": "缺铁性贫血的细胞形态学表现为",
    "options": ["A.小细胞正色素性贫血", "B.小细胞低色素性贫血", "C.正常细胞正色素性贫血", "D.大细胞低色素性贫血", "E.大细胞性贫血"],
    "answer": "B"
  },
  {
    "id": 133,
    "question": "体内缺铁时,最早表现为",
    "options": ["A.血清铁降低", "B.血清总铁结合力增高", "C.贮存铁减少", "D.平均红细胞体积变小", "E.MCH减低"],
    "answer": "C"
  },
  {
    "id": 134,
    "question": "缺铁性贫血患者的实验室检查是",
    "options": ["A.血清铁降低,总铁结合力降低", "B.血清铁降低,总铁结合力正常", "C.血清铁正常,总铁结合力降低", "D.血清铁降低,总铁结合力增高", "E.血清铁和总铁结合力增高"],
    "answer": "D"
  },
  {
    "id": 135,
    "question": "成人引起缺铁性贫血最常见的原因是",
    "options": ["A.摄入减少", "B.胃酸缺乏", "C.慢性失血", "D.胃大部切除术", "E.需要量增加"],
    "answer": "C"
  },
  {
    "id": 136,
    "question": "关于巨幼细胞贫血的叙述,正确的是",
    "options": ["A.小细胞低色素性贫血", "B.粒细胞出现巨型杆状核和核分叶过多", "C.可见胞质发育落后于胞核现象", "D.可出现异食癖、反甲等临床症状", "E.骨髓象主要表现为粒细胞系的巨幼变"],
    "answer": "B"
  },
  {
    "id": 137,
    "question": "缺铁早期的红细胞形态特点为",
    "options": ["A.小细胞正色素性", "B.小细胞低色素性", "C.正常细胞正色素性", "D.大细胞性", "E.大细胞低色素性"],
    "answer": "C"
  },
  {
    "id": 138,
    "question": "再生障碍性贫血骨髓象的最主要特点是",
    "options": ["A.骨髓增生减低", "B.粒红比值正常", "C.淋巴细胞比例增加", "D.血小板减少", "E.巨核细胞明显减少或缺如"],
    "answer": "E"
  },
  {
    "id": 139,
    "question": "关于细胞外铁的叙述,错误的是",
    "options": ["A.反映骨髓中贮存铁的量", "B.主要观察骨髓小粒", "C.是铁的聚合体", "D.可用普鲁士蓝反应显示其存在", "E.正常为弱阳性"],
    "answer": "E"
  },
  {
    "id": 140,
    "question": "与维生素 B12 和叶酸缺乏无关的改变是",
    "options": ["A.细胞分裂增殖加速", "B.细胞体积增大", "C.细胞核染色质疏松", "D.细胞核增大", "E.DNA合成障碍"],
    "answer": "A"
  },
  {
    "id": 141,
    "question": "贫血的Bessman 分型主要依据的指标是",
    "options": ["A.RBC、HCT、MCH", "B.RBC、Hb、HCT", "C.RDW、MCV", "D.RBC、Hb、MCHC", "E.MCV、MCHC、MCH"],
    "answer": "C"
  },
  {
    "id": 142,
    "question": "关于再生障碍性贫血时检查结果的叙述,正确的是",
    "options": ["A.NAP 积分降低", "B.骨髓可染铁减少", "C.体外造血祖细胞培养细胞集落正常", "D.外周血红细胞生成素水平增加", "E.骨髓中原始细胞比例明显升高"],
    "answer": "D"
  },
  {
    "id": 143,
    "question": "关于再生障碍性贫血骨髓象的叙述,错误的是",
    "options": ["A.骨髓有核细胞增生减低", "B.粒红比值正常", "C.骨髓有局部造血灶,伴巨核细胞增生活跃", "D.淋巴细胞、浆细胞、网状细胞增多", "E.造血细胞形态正常"],
    "answer": "C"
  },
  {
    "id": 144,
    "question": "关于重型再生障碍性贫血的叙述,错误的是",
    "options": ["A.骨髓多数部位增生减低或极度减低,少数部位增生活跃", "B.粒系、红系、巨核系细胞明显减少", "C.淋巴细胞、浆细胞、肥大细胞等非造血细胞增多", "D.骨髓小粒呈空网状", "E.涂片上油滴往往增多"],
    "answer": "A"
  },
  {
    "id": 145,
    "question": "符合再生障碍性贫血的外周血表现的是",
    "options": ["A.中性粒细胞百分比及绝对值升高", "B.网织红细胞百分比及绝对值正常", "C.MCV、MCH、MCHC低于正常范围下限", "D.淋巴细胞百分比升高", "E.血小板严重减少,伴形态异常"],
    "answer": "D"
  },
  {
    "id": 146,
    "question": "骨髓中可出现巨原始红细胞的疾病是",
    "options": ["A.缺铁性贫血", "B.再生障碍性贫血危象", "C.纯红再生障碍性贫血", "D.巨幼细胞贫血", "E.铁粒幼细胞贫血"],
    "answer": "D"
  },
  {
    "id": 147,
    "question": "缺铁性贫血患者服用铁剂治疗有效者,迅速增高并常于1周左右达到高峰的指标是",
    "options": ["A.红细胞数", "B.网织红细胞", "C.血红蛋白", "D.平均红细胞体积", "E.平均血红蛋白量"],
    "answer": "B"
  },
  {
    "id": 148,
    "question": "巨幼细胞贫血患者经过有效治疗后,骨髓中形态最先恢复正常的是",
    "options": ["A.巨核系", "B.红系", "C.粒系", "D.单核系", "E.淋巴系"],
    "answer": "B"
  },
  {
    "id": 149,
    "question": "以下最能概括再生障碍性贫血血象主要特点的是",
    "options": ["A.网织红细胞显著减少", "B.血小板显著减少", "C.中性粒细胞减少", "D.血红蛋白明显降低", "E.全血细胞减少"],
    "answer": "E"
  },
  {
    "id": 150,
    "question": "关于继发性再生障碍性贫血的病因的叙述,错误的是",
    "options": ["A.药物和某些化学物质的影响", "B.病毒等感染", "C.电离辐射等物理因素的影响", "D.内分泌疾病", "E.脾功能亢进"],
    "answer": "E"
  },
  {
    "id": 151,
    "question": "在诊断机体缺铁的指标中,最早出现异常的是",
    "options": ["A.血清铁", "B.血清铁蛋白", "C.骨髓铁染色", "D.转铁蛋白饱和度", "E.总铁结合力"],
    "answer": "B"
  },
  {
    "id": 152,
    "question": "关于铁粒幼细胞贫血的诊断依据的叙述,错误的是",
    "options": ["A.小细胞低色素或双向性贫血", "B.细胞内、外铁明显增多", "C.出现大量的环形铁粒幼细胞", "D.总铁结合力明显增高", "E.血清铁和血清铁蛋白均增高"],
    "answer": "D"
  },
  {
    "id": 153,
    "question": "总铁结合力升高的疾病是",
    "options": ["A.肾病综合征", "B.肝硬化", "C.恶性肿瘤", "D.先天性转铁蛋白缺乏", "E.缺铁性贫血"],
    "answer": "E"
  },
  {
    "id": 154,
    "question": "关于纯红细胞再生障碍性贫血诊断标准的叙述,错误的是",
    "options": ["A.血红蛋白及红细胞低于正常值", "B.白细胞、血小板正常", "C.骨髓三系增生减低", "D.网织红细胞比例及绝对值减低", "E.肝、脾、淋巴结一般不大"],
    "answer": "C"
  },
  {
    "id": 155,
    "question": "可鉴别缺铁性贫血与慢性病性贫血的实验室检查是",
    "options": ["A.红细胞内游离原卟啉", "B.血清铁", "C.血清铁蛋白", "D.MCV、MCH、MCHC", "E.血涂片检查"],
    "answer": "C"
  },
  {
    "id": 156,
    "question": "缺铁的实验室确诊依据是",
    "options": ["A.平均红细胞血红蛋白浓度及平均红细胞血红蛋白含量减少", "B.血清铁蛋白水平上升", "C.血清铁水平下降", "D.骨髓储存铁缺乏", "E.MCV 下降"],
    "answer": "D"
  },
  {
    "id": 157,
    "question": "可鉴别缺铁性贫血与铁幼粒细胞贫血的实验室检查是",
    "options": ["A.血清铁饱和度", "B.MCV、MCH、MCHC", "C.骨髓铁染色", "D.红细胞内游离原卟啉", "E.血清总铁结合力"],
    "answer": "C"
  },
  {
    "id": 158,
    "question": "关于铁吸收的叙述,错误的是",
    "options": ["A.高铁化合物比亚铁易吸收", "B.维生素C可增强食物铁的吸收", "C.植物纤维和鞣酸盐之类的食物可干扰铁的吸收", "D.小肠内pH为酸性或中性可加强铁的吸收", "E.其他微量元素如铜可帮助铁吸收"],
    "answer": "A"
  },
  {
    "id": 159,
    "question": "关于缺铁性贫血的叙述,正确的是",
    "options": ["A.血清铁降低,总铁结合力增高,转铁蛋白饱和度正常", "B.血清铁降低,总铁结合力增高,转铁蛋白饱和度降低", "C.血清铁降低,总铁结合力增高,转铁蛋白饱和度增高", "D.血清铁降低,总铁结合力降低,转铁蛋白饱和度增高", "E.血清铁降低,总铁结合力降低,转铁蛋白饱和度降低"],
    "answer": "B"
  },
  {
    "id": 160,
    "question": "关于血清总铁结合力(TIBC)的叙述,错误的是",
    "options": ["A.指血清中转铁蛋白能与铁结合的总量", "B.血清总铁结合力与血清铁蛋白呈正相关", "C.总铁结合力可反映机体转铁蛋白水平", "D.增高可见于缺铁性贫血、红细胞增多症", "E.减低可见于肾病综合征、恶性肿瘤"],
    "answer": "B"
  },
  {
    "id": 161,
    "question": "符合缺铁性贫血血象特点的是",
    "options": ["A.RBC减少比Hb减少明显", "B.粒细胞核分叶增多", "C.MCH > 32 pg", "D.红细胞中央淡染区扩大", "E.粒细胞核左移"],
    "answer": "D"
  },
  {
    "id": 162,
    "question": "巨幼细胞贫血时,血红蛋白测定和红细胞计数变化是",
    "options": ["A.Hb↓, RBC↓", "B.Hb↑, RBC↓", "C.Hb↓, RBC↓↓", "D.Hb↓↓, RBC↓↓", "E.Hb↓, RBC↓"],
    "answer": "C"
  },
  {
    "id": 163,
    "question": "巨幼细胞贫血的血象特点是",
    "options": ["A.易见晚幼红细胞、中性幼稚粒细胞", "B.易见嗜多色性红细胞", "C.可见大红细胞", "D.易见嗜碱性点彩红细胞", "E.中性粒细胞核分叶减少"],
    "answer": "C"
  },
  {
    "id": 164,
    "question": "与维生素 B12 缺乏的巨幼细胞贫血有关的临床表现是",
    "options": ["A.脾轻度增大", "B.心脏有收缩期杂音", "C.口唇苍白", "D.神经系统症状", "E.疲乏无力、食欲减退"],
    "answer": "D"
  },
  {
    "id": 165,
    "question": "关于巨幼细胞贫血的叙述,错误的是",
    "options": ["A.叶酸是DNA合成的必需营养素", "B.维生素 B12 是DNA合成的必需营养素", "C.DNA是细胞增殖的基本物质条件", "D.细胞胞质发育落后于细胞核", "E.为大细胞正色素性贫血"],
    "answer": "D"
  },
  {
    "id": 166,
    "question": "血象表现为全血细胞减少;骨髓呈增生减低,造血细胞减少,非造血细胞增加。符合的疾病是",
    "options": ["A.严重的缺铁性贫血", "B.白血病", "C.脾功能亢进", "D.溶血性贫血", "E.再生障碍性贫血"],
    "answer": "E"
  },
  {
    "id": 167,
    "question": "关于再生障碍性贫血的叙述,错误的是",
    "options": ["A.正常细胞正色素性贫血", "B.网织红细胞绝对值减低", "C.一般无肝、脾和淋巴结肿大", "D.可有发热、出血、贫血", "E.骨髓局部增生灶中可见巨核细胞增多"],
    "answer": "E"
  },
  {
    "id": 168,
    "question": "关于再生障碍性贫血与阵发性睡眠血红蛋白尿症(PNH)的鉴别诊断的叙述,错误的是",
    "options": ["A.PNH 患者可有轻度黄疸", "B.两病均可表现为全血细胞减少", "C.PNH患者可有血红蛋白尿", "D.再生障碍性贫血时酸化血清溶血试验及蔗糖溶血试验也往往阳性", "E.PNH 患者网织红细胞常轻度增高"],
    "answer": "D"
  },
  {
    "id": 169,
    "question": "诊断再生障碍性贫血最准确的检查方法是",
    "options": ["A.骨髓细胞学检查", "B.骨髓活检", "C.血常规检查", "D.骨髓细胞化学染色", "E.骨髓细胞培养"],
    "answer": "B"
  },
  {
    "id": 170,
    "question": "再生障碍性贫血的主要原因是",
    "options": ["A.骨髓造血功能衰竭", "B.造血原料缺乏", "C.红细胞寿命缩短", "D.红细胞破坏过多", "E.红细胞内在缺陷"],
    "answer": "A"
  },{
    "id": 171,
    "question": "支持再生障碍性贫血的实验检查结果是",
    "options": ["A.中性粒细胞碱性磷酸酶积分减低", "B.外周血淋巴细胞比例减低", "C.外周血出现有核红细胞", "D.骨髓中巨核细胞减低", "E.骨髓中非造血细胞减低"],
    "answer": "D"
  },
  {
    "id": 172,
    "question": "外周血 Hb减少比RBC计数减少更为显著的贫血是",
    "options": ["A.再生障碍性贫血", "B.巨幼细胞贫血", "C.缺铁性贫血", "D.肾性贫血", "E.生理性贫血"],
    "answer": "C"
  },
  {
    "id": 173,
    "question": "关于急性重型再生障碍性贫血的叙述,错误的是",
    "options": ["A.发病急骤,临床症状严重,预后较差", "B.血象中网织红细胞百分比>1%", "C.粒细胞绝对值<0.5×10⁹/L", "D.血小板计数 <20×10⁹/L", "E.骨髓增生极度减低或减低"],
    "answer": "B"
  },
  {
    "id": 174,
    "question": "外周血涂片中一般不会出现有核红细胞的疾病是",
    "options": ["A.巨幼细胞贫血", "B.恶性肿瘤骨转移", "C.溶血性贫血", "D.急性失血性贫血", "E.再生障碍性贫血"],
    "answer": "E"
  },
  {
    "id": 175,
    "question": "关于 WHO分型(2016)属于髓系肿瘤分类的叙述,错误的是",
    "options": ["A.系列不明的急性白血病", "B.肥大细胞增多症", "C.母细胞性浆细胞样树突细胞肿瘤", "D.组织细胞和树突状细胞肿瘤", "E.伴嗜酸性粒细胞增多和特殊基因重排的髓系/淋系肿瘤"],
    "answer": "D"
  },
  {
    "id": 176,
    "question": "WHO分型中,将急性髓细胞白血病的骨髓或外周血的原始细胞诊断标准调整为多少",
    "options": ["A.≥5%", "B.≥10%", "C.≥15%", "D.≥20%", "E.≥30%"],
    "answer": "D"
  },
  {
    "id": 177,
    "question": "关于急性白血病四大临床表现的叙述,错误的是",
    "options": ["A.消瘦", "B.出血", "C.贫血", "D.浸润", "E.发热"],
    "answer": "A"
  },
  {
    "id": 178,
    "question": "急性白血病完全缓解骨髓象,其骨髓中的原始细胞占多少",
    "options": ["A.≤1%", "B.≤2%", "C.≤3%", "D.≤5%", "E.≤10%"],
    "answer": "D"
  },
  {
    "id": 179,
    "question": "易浸润牙龈的急性白血病是",
    "options": ["A.急性单核细胞白血病", "B.急性粒细胞白血病", "C.急性淋巴细胞白血病", "D.急性巨核细胞白血病", "E.急性早幼粒细胞白血病"],
    "answer": "A"
  },
  {
    "id": 180,
    "question": "急性白血病至骨髓完全缓解后,其体内还可能存在白血病细胞多少个",
    "options": ["A.10²~10³", "B.10³~10⁵", "C.10⁵~10⁶", "D.10⁶~10⁸", "E.10⁸~10¹⁰"],
    "answer": "D"
  },
  {
    "id": 181,
    "question": "急性淋巴细胞白血病完全缓解复查骨髓,其原始、幼稚淋巴细胞占75%,说明是",
    "options": ["A.急性淋巴细胞白血病骨髓象", "B.急性淋巴细胞白血病复发骨髓象", "C.急性淋巴细胞白血病退步骨髓象", "D.急性淋巴细胞白血病部分缓解骨髓象", "E.急性淋巴细胞白血病未缓解骨髓象"],
    "answer": "B"
  },
  {
    "id": 182,
    "question": "柴捆细胞常出现于",
    "options": ["A.急性粒-单核细胞白血病", "B.急性单核细胞白血病", "C.急性粒细胞白血病", "D.急性早幼粒细胞白血病", "E.急性巨核细胞白血病"],
    "answer": "D"
  },
  {
    "id": 183,
    "question": "关于AML伴重现性遗传学异常的叙述,错误的是",
    "options": ["A.AML伴 NPM1突变", "B.AML伴 WT1 突变", "C.AML伴 CEBPA突变", "D.AML伴(6;9)(p23;q34); DEK-NUP214", "E.AML伴(1;22)(p13;q13); RBM15-MKL1"],
    "answer": "B"
  },
  {
    "id": 184,
    "question": "关于急性髓细胞白血病及相关肿瘤内容的叙述,错误的是",
    "options": ["A.AML伴重现性染色体异常", "B.AML伴骨髓增生异常", "C.治疗相关的髓系肿瘤", "D.AML,非特指型", "E.骨髓增殖性肿瘤"],
    "answer": "E"
  },
  {
    "id": 185,
    "question": "关于成熟B细胞肿瘤分类的叙述,错误的是",
    "options": ["A.淋巴母细胞淋巴瘤", "B.浆母细胞淋巴瘤", "C.Burkitt 淋巴瘤", "D.弥漫大B细胞淋巴瘤", "E.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤"],
    "answer": "A"
  },
  {
    "id": 186,
    "question": "关于移植后淋巴细胞增殖性疾病(PLTD)的叙述,错误的是",
    "options": ["A.发生在患者接受异体的造血干细胞移植和实体器官移植后", "B.是一种继发的淋巴细胞增生或淋巴瘤", "C.多数由B淋巴细胞起源,少数由T淋巴细胞起源", "D.少数与EB病毒感染有关", "E.包括多形性、单形性PLTD等"],
    "answer": "D"
  },
  {
    "id": 187,
    "question": "导致急性白血病死亡的常见原因是",
    "options": ["A.严重贫血", "B.脾破裂", "C.颅内等出血", "D.化疗药的副作用", "E.心力衰竭"],
    "answer": "C"
  },
  {
    "id": 188,
    "question": "关于急性白血病血象特点的叙述,正确的是",
    "options": ["A.多数白细胞数增多", "B.多数血小板数正常", "C.多数红细胞数正常", "D.多数全血细胞数减少", "E.多数血涂片未见白血病细胞"],
    "answer": "A"
  },
  {
    "id": 189,
    "question": "关于急性白血病骨髓象特点的叙述,正确的是",
    "options": ["A.骨髓增生活跃", "B.巨核细胞明显增生", "C.粒红比常明显倒置", "D.急性白血病细胞≥30%", "E.正常造血细胞常明显抑制"],
    "answer": "E"
  },
  {
    "id": 190,
    "question": "未见棒状小体的急性白血病是",
    "options": ["A.急性早幼粒细胞白血病", "B.急性淋巴细胞白血病", "C.急性粒细胞白血病", "D.急性粒单核细胞白血病", "E.急性单核细胞白血病"],
    "answer": "B"
  },
  {
    "id": 191,
    "question": "1995年国际血液学标准化委员会推荐的最少细胞化学染色项目是",
    "options": ["A.MPO、PAS、特异性酯酶", "B.MPO、NAS-DCE、特异性酯酶", "C.MPO、醋酸萘酚酯酶、特异性酯酶", "D.MPO、丁酸萘酚酯酶、特异性酯酶", "E.MPO、酸性磷酸酶、特异性酯酶"],
    "answer": "C"
  },
  {
    "id": 192,
    "question": "属于非系列特异性的单抗是",
    "options": ["A.CD34、CD3、CD41", "B.CD117、CD79a、CD33", "C.CD117、HLA-DR、CD7", "D.TdT、MPO、CD3", "E.CD34、TdT、HLA-DR"],
    "answer": "E"
  },
  {
    "id": 193,
    "question": "关于急性白血病的MICM分型的叙述,错误的是",
    "options": ["A.细胞免疫学分型", "B.细胞形态学分型", "C.细胞遗传学分型", "D.病理组织活检分型", "E.分子生物学分型"],
    "answer": "D"
  },
  {
    "id": 194,
    "question": "AML-M4Eo常出现的染色体异常是",
    "options": ["A.5号染色体", "B.7号染色体", "C.10号染色体", "D.16号染色体", "E.22号染色体"],
    "answer": "D"
  },
  {
    "id": 195,
    "question": "关于急性早幼粒细胞白血病血象特点的叙述,正确的是",
    "options": ["A.多数呈白细胞数、红细胞数及血小板数减少", "B.多数呈白细胞数增加、红细胞数及血小板数减少", "C.多数呈白细胞增加、红细胞数及血小板数正常", "D.多数呈白细胞数减少、红细胞数及血小板数正常", "E.多数呈白细胞数正常、红细胞数及血小板数减少"],
    "answer": "A"
  },
  {
    "id": 196,
    "question": "TCR 重排阳性见于",
    "options": ["A.粒细胞肿瘤", "B.B淋巴细胞肿瘤", "C.单核细胞肿瘤", "D.组织细胞肿瘤", "E.骨髓增殖性肿瘤"],
    "answer": "B"
  },
  {
    "id": 197,
    "question": "全反式维甲酸、亚砷酸用于治疗",
    "options": ["A.急性单核细胞白血病", "B.急性粒-单核细胞白血病", "C.急性淋巴细胞白血病", "D.急性早幼粒细胞白血病", "E.恶性淋巴瘤"],
    "answer": "D"
  },
  {
    "id": 198,
    "question": "慢性髓细胞白血病(CML)中费城染色体的典型易位是",
    "options": ["A.t(15;17)(q22;q12)", "B.inv(16)(p13.1;q22)", "C.t(9;22)(q34;q11)", "D.t(8;21)(q22;q22)", "E.t(11;14)(q13;q32)"],
    "answer": "C"
  },
  {
    "id": 199,
    "question": "关于慢性髓细胞白血病的叙述,错误的是",
    "options": ["A.起源于造血干细胞的骨髓增殖性肿瘤,主要累及粒系", "B.常有脾大", "C.白细胞数增加,有的血小板数>1000×10⁹/L", "D.嗜碱性粒细胞和(或)嗜酸性粒细胞常增多", "E.外周血与骨髓的细胞分类结果往往相差很大"],
    "answer": "E"
  },
  {
    "id": 200,
    "question": "关于真性红细胞增多症的实验室检查的叙述,错误的是",
    "options": ["A.外周血白细胞及血小板数也常增加", "B.骨髓以红系明显增生为主", "C.幼红细胞常有形态异常", "D.NAP 积分常明显增高", "E.WHO分型中,男性 Hb>165g/L,女性 Hb>160g/L"],
    "answer": "C"
  },
  {
    "id": 201,
    "question": "提示慢性髓细胞白血病伴骨髓发生纤维化的是",
    "options": ["A.血红蛋白量明显下降", "B.白细胞数进行性增加", "C.外周血中嗜碱性粒细胞增加", "D.外周血中易见泪滴形细胞", "E.出现新的克隆性染色体异常"],
    "answer": "D"
  },
  {
    "id": 202,
    "question": "关于慢性髓细胞白血病加速期的诊断标准的叙述,错误的是",
    "options": ["A.外周血嗜碱性粒细胞≥20%", "B.血小板持续增多(>1000×10⁹/L)", "C.血小板持续性减低(<100×10⁹/L)", "D.外周血中原始细胞占25%", "E.脾大且治疗无效"],
    "answer": "D"
  },
  {
    "id": 203,
    "question": "2016年WHO分型中,关于骨髓增殖性肿瘤的叙述,错误的是",
    "options": ["A.慢性嗜酸性粒细胞白血病,非特指型", "B.原发性骨髓纤维化", "C.慢性中性粒细胞白血病", "D.真性红细胞增多症", "E.肥大细胞增多症"],
    "answer": "E"
  },
  {
    "id": 204,
    "question": "原发性血小板增多症(ET)的主要诊断标准中,外周血血小板数为",
    "options": ["A.≥300×10⁹/L", "B.≥450×10⁹/L", "C.≥500×10⁹/L", "D.≥600×10⁹/L", "E.≥1000×10⁹/L"],
    "answer": "B"
  },
  {
    "id": 205,
    "question": "关于原发性骨髓纤维化的叙述,错误的是",
    "options": ["A.为正常细胞正色素性贫血", "B.患者骨髓中造血细胞均减少", "C.脾脏常明显增大", "D.骨髓活检可见网硬蛋白、胶原蛋白纤维增生", "E.外周血易见有核红细胞、幼稚粒细胞"],
    "answer": "B"
  },
  {
    "id": 206,
    "question": "关于慢性髓细胞白血病和骨髓纤维化鉴别要点的叙述,错误的是",
    "options": ["A.脾大", "B.血常规检查", "C.细胞化学染色", "D.融合基因检查", "E.染色体检查"],
    "answer": "A"
  },
  {
    "id": 207,
    "question": "对诊断骨髓增殖性肿瘤意义不大的基因是",
    "options": ["A.CSF3R", "B.JAK2", "C.CALR", "D.MPL", "E.SF3B1"],
    "answer": "E"
  },
  {
    "id": 208,
    "question": "毛细胞白血病的特征性超微结构特点是",
    "options": ["A.细胞表面有毛状突起", "B.细胞表面呈皱折状突起", "C.细胞表面有伪足", "D.胞质内高尔基体高度发育", "E.胞质内可见核糖体板层复合物"],
    "answer": "E"
  },
  {
    "id": 209,
    "question": "毛细胞白血病多不表达",
    "options": ["A.CD5", "B.CD20", "C.CD25", "D.CD103", "E.CD123"],
    "answer": "A"
  },
  {
    "id": 210,
    "question": "与HTLV-1病毒相关的疾病是",
    "options": ["A.Burkitt 淋巴瘤", "B.成人T细胞白血病/淋巴瘤", "C.幼淋巴细胞白血病", "D.毛细胞白血病", "E.大颗粒淋巴细胞白血病"],
    "answer": "B"
  },
  {
    "id": 211,
    "question": "幼淋巴细胞白血病外周血中幼淋巴细胞应",
    "options": ["A.>20%", "B.>30%", "C.>40%", "D.>45%", "E.>55%"],
    "answer": "E"
  },
  {
    "id": 212,
    "question": "关于大颗粒淋巴细胞白血病(LGLL)的叙述,错误的是",
    "options": ["A.归在成熟T/NK细胞肿瘤中", "B.依靠骨髓/外周血大颗粒淋巴细胞及特征性表型", "C.大颗粒淋巴细胞染色质呈细颗粒状,易见清晰核仁", "D.多数临床上表现为惰性病程", "E.多数为T细胞型 LGLL"],
    "answer": "C"
  },
  {
    "id": 213,
    "question": "骨髓增生异常综合征最常见的临床表现是",
    "options": ["A.贫血", "B.出血", "C.脾大", "D.高热", "E.胸骨压痛"],
    "answer": "A"
  },
  {
    "id": 214,
    "question": "关于MDS伴多系发育异常(MDS-MLD)的叙述,错误的是",
    "options": ["A.外周血一系或多系减少", "B.骨髓原始细胞<5%", "C.外周血原始细胞<1%,可见Auer小体", "D.外周血单核细胞<1×10⁹/L", "E.环形铁粒幼红细胞可≥15%"],
    "answer": "C"
  },
  {
    "id": 215,
    "question": "关于MDS伴孤立5q缺失的叙述,错误的是",
    "options": ["A.外周血细胞数1-3系减少", "B.骨髓原始细胞<5%,外周血<1%", "C.中位生存期长,转白风险小", "D.巨核细胞分叶减少或不分叶", "E.仅有del(5q)或伴1个除-7或del(7q)外的异常"],
    "answer": "A"
  },
  {
    "id": 216,
    "question": "关于慢性嗜酸性粒细胞白血病(非特指型)的叙述,错误的是",
    "options": ["A.以中青年为多,男性多于女性", "B.临床症状由嗜酸性粒细胞浸润引起", "C.外周血嗜酸性粒细胞≥1.5×10⁹/L且有形态异常", "D.骨髓中原始细胞<20%", "E.常有PDGFRA或PDGFRB 基因的重排"],
    "answer": "E"
  },
  {
    "id": 217,
    "question": "慢性髓细胞白血病慢性期患者,骨髓中原始细胞为",
    "options": ["A.<2%", "B.<5%", "C.<10%", "D.<15%", "E.<20%"],
    "answer": "C"
  },
  {
    "id": 218,
    "question": "关于急性原始单核细胞白血病骨髓中原始单核细胞比例的叙述,正确的是",
    "options": ["A.≥20%", "B.≥80%", "C.≥80%(NEC)", "D.≥90%", "E.≥90%(NEC)"],
    "answer": "B"
  },
  {
    "id": 219,
    "question": "关于非霍奇金淋巴瘤的特点的叙述,错误的是",
    "options": ["A.临床最常见一类淋系肿瘤", "B.以成熟B细胞肿瘤占绝大多数", "C.侵犯呈跳跃式,骨髓也常受侵", "D.结外病变比霍奇金淋巴瘤少见", "E.预后比霍奇金淋巴瘤差"],
    "answer": "D"
  },
  {
    "id": 220,
    "question": "关于红血病骨髓主要诊断标准的叙述,正确的是",
    "options": ["A.原始红细胞≥20%,红系≥50%", "B.原始红细胞≥20%,红系≥60%", "C.原始红细胞≥20%,红系≥80%", "D.原始红细胞≥30%,红系≥50%", "E.原始红细胞≥30%,红系≥80%"],
    "answer": "E"
  },
  {
    "id": 221,
    "question": "最易并发中枢神经系统白血病(CNSL)的是",
    "options": ["A.急性髓系白血病成熟型", "B.急性淋巴细胞白血病", "C.急性髓系白血病微分化型", "D.急性单核细胞白血病", "E.慢性淋巴细胞白血病"],
    "answer": "B"
  },
  {
    "id": 222,
    "question": "关于慢性淋巴细胞白血病实验室检查的叙述,错误的是",
    "options": ["A.外周血B淋巴细胞绝对值≥5×10⁹/L", "B.骨髓中原始和幼稚淋巴细胞比例>10%", "C.慢淋细胞与正常小淋巴细胞难以区别", "D.骨髓淋巴细胞常>40%,易见涂抹细胞", "E.白细胞数增加,红系及板正常或减少"],
    "answer": "B"
  },
  {
    "id": 223,
    "question": "临床上诊断淋巴瘤最重要、最常用的实验室检查手段是",
    "options": ["A.骨髓检查", "B.组织病理学检查", "C.细胞免疫学分型", "D.细胞遗传学检查", "E.分子生物学检查"],
    "answer": "B"
  },
  {
    "id": 224,
    "question": "关于慢性淋巴细胞白血病的叙述,错误的是",
    "options": ["A.与小淋巴细胞淋巴瘤是同一生物学实体", "B.与慢性髓细胞白血病相似,易发生急变", "C.起病缓慢,预后差别大", "D.易并发各种感染,是常见的死因", "E.部分患者终身无需治疗而不影响生存"],
    "answer": "B"
  },
  {
    "id": 225,
    "question": "关于霍奇金淋巴瘤 WHO分型的叙述,错误的是",
    "options": ["A.结节性混合细胞为主型", "B.结节硬化型", "C.混合细胞型", "D.淋巴细胞消减型", "E.富含淋巴细胞型"],
    "answer": "A"
  },
  {
    "id": 226,
    "question": "关于慢性淋巴细胞白血病的细胞遗传学和分子生物学检查的叙述,错误的是",
    "options": ["A.一般采用常规染色体核型分析", "B.多数有克隆性核型异常", "C.常见+12、13q-、11q-、17p-等", "D.核型异常与预后有关", "E.50%~60%患者有IgVH突变"],
    "answer": "A"
  },
  {
    "id": 227,
    "question": "Burkitt 淋巴瘤可能与下列哪种病毒感染有关",
    "options": ["A.轮状病毒", "B.流感病毒", "C.巨细胞病毒", "D.EB病毒", "E.腺病毒"],
    "answer": "D"
  },
  {
    "id": 228,
    "question": "关于急性淋巴细胞白血病骨髓象特点的叙述,错误的是",
    "options": ["A.原始、幼稚淋巴细胞比例≥20%", "B.原、幼淋胞质中偶见 Auer 小体", "C.原、幼淋具有胞体小、胞质少等特点", "D.易见涂抹细胞", "E.骨髓增生明显活跃或极度活跃"],
    "answer": "B"
  },
  {
    "id": 229,
    "question": "关于中枢神经系统白血病的叙述,错误的是",
    "options": ["A.急性髓细胞白血病中以急性早幼粒细胞白血病为多见", "B.常表现为颅内压升高症状", "C.脑脊液中白细胞数>0.01×10⁹/L", "D.脑脊液中蛋白质>450mg/L", "E.涂片见到白血病细胞"],
    "answer": "A"
  },
  {
    "id": 230,
    "question": "急性巨核细胞白血病的诊断标准为",
    "options": ["A.骨髓原始细胞≥20%,其中≥30%为巨核细胞", "B.骨髓原始细胞≥20%,其中≥50%为巨核细胞", "C.骨髓原始细胞≥30%,其中≥30%为巨核细胞", "D.骨髓原始细胞≥30%,其中≥50%为巨核细胞", "E.骨髓原始细胞≥30%,其中≥80%为巨核细胞"],
    "answer": "B"
  },
  {
    "id": 231,
    "question": "经典型霍奇金淋巴瘤起源于",
    "options": ["A.NK细胞", "B.T细胞", "C.B细胞", "D.淋巴细胞", "E.组织细胞"],
    "answer": "C"
  },
  {
    "id": 232,
    "question": "与幽门螺杆菌(Hp)感染相关的是",
    "options": ["A.黏膜相关淋巴组织淋巴瘤", "B.弥漫大B细胞淋巴瘤", "C.Burkitt 淋巴瘤", "D.间变性大细胞淋巴瘤", "E.套细胞淋巴瘤"],
    "answer": "A"
  },
  {
    "id": 233,
    "question": "急性巨核细胞白血病的细胞免疫表型是",
    "options": ["A.CD13, CD14, CD15, CD33及HLA-DR 阳性", "B.CD19, CD20, CD22, sIg及HLA-DR阳性", "C.CD11b, CD41a及HLA-DR阳性", "D.CD41a, CD41b及PPO阳性", "E.CD10, CD15, CD62及PPO 阳性"],
    "answer": "D"
  },
  {
    "id": 234,
    "question": "慢性淋巴细胞白血病的细胞免疫学特点是",
    "options": ["A.CD2+, CD3+, CD4+, CD5+", "B.CD4+, CD5+, CD7, CD8+", "C.CD4+, CD5+, CD19+, CD20+", "D.CD10+, CD19+, CD20-, CD25+", "E.CD5+, CD19+, CD20+/-, CD23+"],
    "answer": "E"
  },
  {
    "id": 235,
    "question": "急性淋巴细胞白血病的细胞化学染色结果是",
    "options": ["A.PAS染色多呈粗颗粒状或块状阳性", "B.NAS-DCE染色阳性", "C.NAP 染色积分降低", "D.NAS-DAE染色阳性,且被NaF 抑制", "E.MPO染色阳性率>3%"],
    "answer": "A"
  },
  {
    "id": 236,
    "question": "关于急性淋巴细胞白血病细胞免疫学分型4型的叙述,错误的是",
    "options": ["A.早前急性淋巴细胞白血病", "B.普通急性淋巴细胞白血病", "C.特殊急性淋巴细胞白血病", "D.前急性B淋巴细胞白血病", "E.成熟急性淋巴细胞白血病"],
    "answer": "C"
  },
  {
    "id": 237,
    "question": "关于 NHL细胞遗传学特点的叙述,错误的是",
    "options": ["A.CLL/SLL多数具有t(2;5)", "B.Burkitt 淋巴瘤多数具有t(8;14)", "C.套细胞淋巴瘤多数具有t(11;14)", "D.MALT多数具有t(11;18)", "E.滤泡淋巴瘤具有多数具有t(14;18)"],
    "answer": "A"
  },
  {
    "id": 238,
    "question": "WHO分型中,关于骨髓增生异常/骨髓增殖性肿瘤的叙述,错误的是",
    "options": ["A.慢性髓细胞白血病", "B.不典型慢性髓细胞白血病", "C.慢性粒-单核细胞白血病", "D.幼年型粒-单核细胞白血病", "E.MDS/MPN,不能分类型"],
    "answer": "A"
  },
  {
    "id": 239,
    "question": "慢性粒-单核细胞白血病血象的主要特点是",
    "options": ["A.白细胞数增加", "B.血小板数减少", "C.幼稚粒细胞≥10%", "D.血细胞形态改变", "E.单核细胞持续增加(≥1.0×10⁹/L),单核≥10%"],
    "answer": "E"
  },
  {
    "id": 240,
    "question": "关于慢性髓细胞白血病与不典型慢性髓细胞白血病鉴别叙述错误的是",
    "options": ["A.细胞化学染色", "B.血小板数有否明显增加", "C.粒系是否存在发育异常", "D.骨髓及外周血中原始细胞比例", "E.外周血中嗜碱性粒细胞的比例"],
    "answer": "D"
  },
  {
    "id": 241,
    "question": "幼年型粒-单核细胞白血病多发生在",
    "options": ["A.<1岁", "B.<4岁", "C.<8岁", "D.<10岁", "E.<12岁"],
    "answer": "B"
  },
  {
    "id": 242,
    "question": "诊断浆细胞白血病最有价值的是",
    "options": ["A.临床上有急性白血病症状", "B.骨髓中异常浆细胞明显增加", "C.血清及尿中出现异常单克隆 Ig", "D.外周血浆细胞数量或比例", "E.是否有骨髓瘤病史"],
    "answer": "D"
  },
  {
    "id": 243,
    "question": "关于可能出现巨脾的疾病的叙述,错误的是",
    "options": ["A.慢性髓细胞白血病", "B.阵发性睡眠性血红蛋白尿症", "C.戈谢病", "D.尼曼匹克病", "E.原发性骨髓纤维化"],
    "answer": "B"
  },
  {
    "id": 244,
    "question": "多发性骨髓瘤最常见的M蛋白类型是",
    "options": ["A.IgG型", "B.IgA型", "C.IgD型", "D.IgM 型", "E.轻链型"],
    "answer": "A"
  },
  {
    "id": 245,
    "question": "关于多发性骨髓瘤的生化检测的叙述,错误的是",
    "options": ["A.血清碱性磷酸酶常明显增高", "B.血清钙常升高", "C.肾功能不全时,血磷可增高", "D.血清LDH 增高程度与预后无关", "E.血清 β2 微球蛋白增高与预后有关"],
    "answer": "D"
  },
  {
    "id": 246,
    "question": "尼曼匹克病是由于缺乏",
    "options": ["A.神经鞘磷脂酶", "B.β-葡萄糖脑苷脂酶", "C.半乳糖脑苷脂酶", "D.类脂代谢酶", "E.溶酶体中水解酶"],
    "answer": "A"
  },
  {
    "id": 247,
    "question": "关于噬血细胞综合征的叙述,错误的是",
    "options": ["A.骨髓中可见噬血细胞", "B.低纤维蛋白血症", "C.NK细胞活性增加", "D.高甘油三酯血症", "E.血清铁蛋白增加"],
    "answer": "B"
  },
  {
    "id": 248,
    "question": "关于MM患者轻链的叙述,错误的是",
    "options": ["A.MM 患者骨髓瘤细胞分泌的重链多于轻链", "B.轻链具有限制性,不是κ即为λ", "C.超过重吸收范围即随尿排出", "D.对诊断及疗效判断具重要意义", "E.尿液中的轻链即为本周蛋白"],
    "answer": "A"
  },
  {
    "id": 249,
    "question": "关于原发性浆细胞白血病的叙述,错误的是",
    "options": ["A.无明确浆细胞病病史", "B.多见于老年人,骨质破坏较骨髓瘤重", "C.临床表现似急性白血病", "D.多数患者有肝、脾和淋巴结肿大", "E.骨髓象特点与骨髓瘤相似"],
    "answer": "B"
  },
  {
    "id": 250,
    "question": "关于意义未定的单克隆免疫球蛋白病的叙述,错误的是",
    "options": ["A.是一种原发性的单克隆血症", "B.好发于老年人", "C.不会转化为多发性骨髓瘤", "D.一般无临床症状", "E.病因尚未清楚"],
    "answer": "C"
  },
  {
    "id": 251,
    "question": "类白血病反应是指",
    "options": ["A.血象三系减少,但有幼稚细胞", "B.无明显变化,但有白血病骨髓象", "C.类似白血病,并无白血病骨髓象", "D.白细胞数>15×10⁹/L", "E.血象中无白血病细胞"],
    "answer": "C"
  },
  {
    "id": 252,
    "question": "引起粒细胞减少症、缺乏症最主要的原因是",
    "options": ["A.药物", "B.射线", "C.毒素", "D.感染", "E.遗传"],
    "answer": "A"
  },
  {
    "id": 253,
    "question": "浆细胞白血病血象的主要特点是",
    "options": ["A.浆细胞≥10%或绝对值≥1×10⁹/L", "B.浆细胞≥10%或绝对值≥2×10⁹/L", "C.浆细胞≥20%或绝对值≥2×10⁹/L", "D.浆细胞≥20%或绝对值≥3×10⁹/L", "E.浆细胞≥10%或绝对值≥3×10⁹/L"],
    "answer": "C"
  },
  {
    "id": 254,
    "question": "鉴别慢性髓细胞白血病与类白血病反应的要点是",
    "options": ["A.血涂片中幼稚粒细胞比例", "B.是否存在基础疾病", "C.细胞化学染色", "D.骨髓增生程度", "E.染色体检查"],
    "answer": "E"
  },
  {
    "id": 255,
    "question": "多数不典型慢性髓细胞白血病存在染色体异常,最常见为",
    "options": ["A.i(11q)", "B.-5/del(5q)", "C.t(9:22)", "D.+8和 del(20q)", "E.del(14p)"],
    "answer": "D"
  },
  {
    "id": 256,
    "question": "诊断传染性单核细胞增多症最有意义的是",
    "options": ["A.EBV-VCA IgG阳性", "B.EBV-VCA IgM阳性", "C.嗜异性凝集试验阳性", "D.单点试验阳性", "E.肝功能异常"],
    "answer": "B"
  },
  {
    "id": 257,
    "question": "关于类白血病反应的血象特点的叙述,错误的是",
    "options": ["A.白细胞可不增加", "B.血小板数正常或增加", "C.血红蛋白无明显变化", "D.以中性粒细胞型最为常见", "E.中性粒细胞型幼稚粒细胞一般<30%"],
    "answer": "E"
  },
  {
    "id": 258,
    "question": "临床上出血时间测定通常用的方法是",
    "options": ["A.DUKE 法", "B.IVY 法", "C.模板法或测定器法", "D.三棱针法", "E.试管法"],
    "answer": "C"
  },
  {
    "id": 259,
    "question": "出血时间测定一般不作为常规筛选试验的主要原因是",
    "options": ["A.成本昂贵", "B.灵敏度低", "C.很不准确,干扰多", "D.特异性低", "E.切口稍大"],
    "answer": "E"
  },
  {
    "id": 260,
    "question": "关于血管性血友病因子功能分析试验的叙述,错误的是",
    "options": ["A.vWF 多聚体分析", "B.vWF的胶原结合能力", "C.瑞斯托霉素诱导的血小板凝集", "D.vWF的FVIII结合能力", "E.血浆vWF瑞斯托霉素辅因子"],
    "answer": "A"
  },
  {
    "id": 261,
    "question": "vWF:Ag缺如,而无vWF多聚体,见于",
    "options": ["A.vWD1型", "B.vWD2A亚型", "C.WD2B 亚型", "D.vWD2N 亚型", "E.vWD3型"],
    "answer": "E"
  },
  {
    "id": 262,
    "question": "血管性血友病2A亚型的主要异常是vWF",
    "options": ["A.与因子X结合力下降", "B.缺乏大、中分子多聚体", "C.抗原含量下降", "D.与胶原结合能力下降", "E.与FVIII结合力降"],
    "answer": "B"
  },
  {
    "id": 263,
    "question": "反映血管内皮损伤程度的指标是",
    "options": ["A.F1+2", "B.ET-1", "C.GP", "D.TXB2", "E.TAT"],
    "answer": "B"
  },
  {
    "id": 264,
    "question": "关于反映血管内皮细胞损伤标志物的叙述,错误的是",
    "options": ["A.6-keto-PGF1α", "B.内皮素(ET)", "C.血栓烷 B₂", "D.DM-6-keto-PGF1α", "E.血栓调节蛋白"],
    "answer": "C"
  },
  {
    "id": 265,
    "question": "不会出现血小板黏附率增高的疾病是",
    "options": ["A.脑血栓", "B.巨血小板综合征", "C.妊娠高血压", "D.糖尿病肾病", "E.动脉粥样硬化"],
    "answer": "B"
  },
  {
    "id": 266,
    "question": "不会出现血小板黏附率降低的疾病是",
    "options": ["A.血小板无力症", "B.肾小球肾炎", "C.肝硬化", "D.服用抗板药", "E.血管性血友病"],
    "answer": "B"
  },
  {
    "id": 267,
    "question": "关于血小板聚集试验常用诱导剂的叙述,错误的是",
    "options": ["A.5-羟色胺", "B.胶原", "C.ADP", "D.肾上腺素", "E.花生四烯酸"],
    "answer": "A"
  },
  {
    "id": 268,
    "question": "临床最常用的血小板聚集试验检测方法是",
    "options": ["A.全血电阻抗法", "B.免疫凝胶法", "C.剪切诱导法", "D.光学比浊法", "E.自发性试验"],
    "answer": "D"
  },
  {
    "id": 269,
    "question": "血小板聚集功能减退可见于",
    "options": ["A.心绞痛", "B.动脉粥样硬化", "C.糖尿病", "D.高脂蛋白血症", "E.肝硬化"],
    "answer": "E"
  },
  {
    "id": 270,
    "question": "血小板聚集功能增高可见于",
    "options": ["A.血小板无力症", "B.巨血小板综合征", "C.心绞痛", "D.板储存池缺陷", "E.尿毒症"],
    "answer": "C"
  },
  {
    "id": 271,
    "question": "关于血小板膜糖蛋白的叙述,错误的是",
    "options": ["A.分质膜和颗粒膜糖蛋白", "B.质膜糖蛋白缺乏是活化标志", "C.对遗传性缺陷具诊断价值", "D.以百分率表示", "E.血小板无力症CD61减低"],
    "answer": "B"
  },
  {
    "id": 272,
    "question": "血浆 β-TG 和 PF4 不会增高的疾病是",
    "options": ["A.冠心病", "B.动脉粥样硬化", "C.糖尿病", "D.高血压", "E.血友病"],
    "answer": "E"
  },
  {
    "id": 273,
    "question": "测定血浆 β-TG 和 PF4 的含量,可以反映",
    "options": ["A.血小板活化", "B.血小板质量", "C.血小板形态", "D.血小板聚集", "E.血小板生存时间"],
    "answer": "A"
  },
  {
    "id": 274,
    "question": "关于血小板自身抗体测定 (PAIg) 对ITP诊断意义叙述错误的是",
    "options": ["A.PAIgG 可增高", "B.PAIgM 可增高", "C.PAIgA 可增高", "D.是特异性试验,有确诊意义", "E.需结合临床"],
    "answer": "D"
  },
  {
    "id": 275,
    "question": "关于全血凝固时间测定的叙述,正确的是",
    "options": ["A.一般采用玻片法", "B.筛选外源凝血有无异常", "C.利用离体静脉血与玻璃接触原理", "D.因子FVIII激活使血液凝固", "E.其准确性高"],
    "answer": "C"
  },
  {
    "id": 276,
    "question": "会导致血浆凝血酶原时间延长的疾病是",
    "options": ["A.先天性FV增多症", "B.高凝状态", "C.避孕药", "D.原发性纤溶亢进", "E.血栓性疾病"],
    "answer": "D"
  },
  {
    "id": 277,
    "question": "关于血浆凝血酶原时间常用报告方式的叙述,错误的是",
    "options": ["A.PT(s)", "B.INR", "C.ISI", "D.PTR", "E.PTA"],
    "answer": "C"
  },
  {
    "id": 278,
    "question": "各种因子缺乏和血浆凝血酶原时间延长无关的是",
    "options": ["A.FII", "B.FV", "C.FVIII", "D.FVII", "E.FX"],
    "answer": "D"
  },
  {
    "id": 279,
    "question": "活化部分凝血活酶时间测定试验中,一般不需要的是",
    "options": ["A.适量钙离子", "B.白陶土", "C.部分凝血活酶", "D.正常血浆", "E.乏基质血浆"],
    "answer": "E"
  },
  {
    "id": 280,
    "question": "活化部分凝血活酶时间测定试验的部分凝血活酶是指",
    "options": ["A.氯化钙溶液", "B.代替血小板的磷脂", "C.组织因子", "D.纤维蛋白原", "E.白陶土"],
    "answer": "B"
  },
  {
    "id": 281,
    "question": "各种因子缺乏和活化部分凝血活酶时间延长无关的是",
    "options": ["A.FVIII", "B.FVII", "C.FIX", "D.FXI", "E.FXII"],
    "answer": "A"
  },
  {
    "id": 282,
    "question": "男性,膝关节撞伤后局部逐渐肿大、疼痛,过去有类似病史,应首选",
    "options": ["A.BT", "B.PT", "C.CT", "D.APTT", "E.PLT"],
    "answer": "D"
  },
  {
    "id": 283,
    "question": "会导致 APTT延长的疾病是",
    "options": ["A.过敏性紫癜", "B.严重肝脏疾病", "C.妊娠高血压", "D.肾病综合征", "E.DIC 高凝期"],
    "answer": "B"
  },
  {
    "id": 284,
    "question": "某患者 APTT为50s/35s, PT为13s/11s,最可能的原因是",
    "options": ["A.FII缺陷", "B.FV缺陷", "C.FVIII缺陷", "D.FVII缺陷", "E.FX缺陷"],
    "answer": "D"
  },
  {
    "id": 285,
    "question": "某患者 APTT为55s/35s,PT为21s/11s,最可能的缺陷是",
    "options": ["A.FVIII", "B.FVII", "C.FXII", "D.FX、FV、FII、Fg", "E.PK、HMWK、FXI、FXII"],
    "answer": "D"
  },
  {
    "id": 286,
    "question": "活化部分凝血活酶时间的参考区间为",
    "options": ["A.12-14 s", "B.16-18 s", "C.25-35 s", "D.2-5 min", "E.<15 min"],
    "answer": "C"
  },
  {
    "id": 287,
    "question": "血浆凝血酶时间的参考区间为",
    "options": ["A.12-14s", "B.16-18 s", "C.2-5 min", "D.25-35 s", "E.<15 min"],
    "answer": "B"
  },
  {
    "id": 288,
    "question": "血浆凝血酶时间延长,见于",
    "options": ["A.原发性或继发性纤溶亢进", "B.原发性血小板增多症", "C.血友病A", "D.FVIII缺乏", "E.FXI缺乏"],
    "answer": "A"
  },
  {
    "id": 289,
    "question": "血浆纤维蛋白原降低可见于",
    "options": ["A.肾病综合征", "B.急性心肌梗死", "C.DIC 晚期", "D.妊娠高血压", "E.风湿性关节炎"],
    "answer": "C"
  },
  {
    "id": 290,
    "question": "一步法乏因子血浆纠正试验检测FX:C所需试剂错误的是",
    "options": ["A.标准血浆", "B.乏因子X血浆", "C.白陶土", "D.组织凝血活酶", "E.氯化钙"],
    "answer": "C"
  },
  {
    "id": 291,
    "question": "一步法乏因子血浆纠正试验检测FVII:C所需试剂错误的是",
    "options": ["A.标准血浆", "B.乏因子VII血浆", "C.白陶土", "D.组织凝血活酶", "E.氯化钙"],
    "answer": "D"
  },
  {
    "id": 292,
    "question": "关于“凝血常规”检测项目的叙述,错误的是",
    "options": ["A.APTT", "B.PT", "C.TT", "D.Fg", "E.CT"],
    "answer": "E"
  },
  {
    "id": 293,
    "question": "关于血浆组织因子含量或活性增加的病因的叙述,错误的是",
    "options": ["A.严重创伤", "B.休克", "C.急性早幼粒细胞白血病", "D.血友病", "E.心肌梗死"],
    "answer": "D"
  },
  {
    "id": 294,
    "question": "反映凝血因子在体内活化的分子标志物是",
    "options": ["A.Fg", "B.PF3", "C.TXB2", "D.GMP-140", "E.F1+2"],
    "answer": "E"
  },
  {
    "id": 295,
    "question": "关于凝血活化分子标志物的叙述,错误的是",
    "options": ["A.TAT", "B.FPA", "C.FPB", "D.F1+2", "E.PAP"],
    "answer": "E"
  },
  {
    "id": 296,
    "question": "关于血栓弹力图的叙述,错误的是",
    "options": ["A.动态监测整个凝血过程", "B.需要少量血液,人为因素小", "C.操作较为复杂", "D.所有参数均为国际标准化", "E.参数包括R、K、a值等"],
    "answer": "C"
  },
  {
    "id": 297,
    "question": "血浆抗凝血酶水平降低,见于",
    "options": ["A.肾病综合征", "B.血友病A", "C.白血病", "D.再障急性出血期", "E.口服抗凝剂"],
    "answer": "A"
  },
  {
    "id": 298,
    "question": "II型遗传性PC缺陷症是指",
    "options": ["A.PC:A下降,PC:Ag正常", "B.PC:A下降,PC:Ag下降", "C.PC:A正常,PC:Ag正常", "D.PC:A正常,PC:Ag下降", "E.PC:A下降,PC:Ag增加"],
    "answer": "A"
  },
  {
    "id": 299,
    "question": "PC:Ag检测常采用",
    "options": ["A.酶联免疫吸附试验", "B.免疫比浊法", "C.发色底物法", "D.一步凝固法", "E.免疫火箭电泳法"],
    "answer": "E"
  },
  {
    "id": 300,
    "question": "合成血浆组织因子途径抑制物(TFPI)的细胞是",
    "options": ["A.单核细胞", "B.原始红细胞", "C.血管内皮细胞", "D.白细胞", "E.自然杀伤细胞"],
    "answer": "C"
  },
  {
    "id": 301,
    "question": "关于血浆狼疮抗凝物检测的叙述,错误的是",
    "options": ["A.采用改良的蛇毒时间检测", "B.包括筛查和确认试验", "C.阳性见于自免病、病毒感染", "D.标准化NLR <2.4", "E.根据 NLR 大小分度"],
    "answer": "D"
  },
  {
    "id": 302,
    "question": "1个 Bethesda 抑制单位相当于",
    "options": ["A.灭活30%凝血因子", "B.灭活40%凝血因子", "C.灭活50%凝血因子", "D.灭活60%凝血因子", "E.灭活70%凝血因子"],
    "answer": "C"
  },
  {
    "id": 303,
    "question": "血浆纤溶酶原增高可见于",
    "options": ["A.肝硬化", "B.原发性纤溶亢进", "C.某些恶性肿瘤", "D.溶栓治疗", "E.继发性纤溶亢进"],
    "answer": "C"
  },
  {
    "id": 304,
    "question": "免疫比浊法检测血浆D-二聚体,大于多少具有临床意义",
    "options": ["A.>0.1 mg/L", "B.>0.5 mg/L", "C.>1.0 mg/L", "D.>1.5 mg/L", "E.>2.0 mg/L"],
    "answer": "B"
  },
  {
    "id": 305,
    "question": "关于反映纤溶活性试验的叙述,错误的是",
    "options": ["A.血浆 FDP测定", "B.LAC筛查试验", "C.D-二聚体定性及定量", "D.3P 试验", "E.纤维蛋白肽测定"],
    "answer": "B"
  },
  {
    "id": 306,
    "question": "筛查与辅助诊断血栓性疾病最常用的项目是",
    "options": ["A.血浆 D-二聚体", "B.APTT", "C.PT", "D.纤维蛋白肽含量", "E.FDP"],
    "answer": "A"
  },
  {
    "id": 307,
    "question": "关于血浆D-二聚体检测的叙述,错误的是",
    "options": ["A.深静脉血栓显著升高", "B.陈旧性血栓可不增高", "C.静脉血栓增高不如动脉显著", "D.早期诊断早于FDP及3P", "E.监测溶栓比FDP有意义"],
    "answer": "C"
  },
  {
    "id": 308,
    "question": "FDP 阳性,D-二聚体正常,最可能的原因是",
    "options": ["A.血栓性疾病", "B.血栓前状态", "C.溶栓治疗后", "D.原发性纤溶亢进", "E.继发性纤溶亢进"],
    "answer": "D"
  },
  {
    "id": 309,
    "question": "关于3P试验的叙述,错误的是",
    "options": ["A.不需要凝血酶", "B.对继发性纤溶特异性高", "C.对继发性纤溶敏感性差", "D.作为手工项目现较少用", "E.DIC早、中、晚期均强阳性"],
    "answer": "E"
  },
  {
    "id": 310,
    "question": "关于血液流变学检验的叙述,错误的是",
    "options": ["A.包括粘度、变形性等", "B.粘度降低见于各类贫血", "C.血浆粘度升高见于高蛋白", "D.红细胞变形性增高见于血栓", "E.检测有激光法和滤膜法"],
    "answer": "D"
  },
  {
    "id": 311,
    "question": "二期止血缺陷是指",
    "options": ["A.血液凝血因子和抗凝功能异常", "B.血小板和血管壁功能异常", "C.血小板和凝血因子异常", "D.抗凝和纤溶功能异常", "E.血浆纤溶活性功能异常"],
    "answer": "A"
  },
  {
    "id": 312,
    "question": "皮肤、黏膜出血表现,一般选用的筛选试验是",
    "options": ["A.PLT, PT, TT", "B.APTT, PT, TT", "C.BT, PLT", "D.BT, PLT, vWF:Ag", "E.Fg, D-D"],
    "answer": "C"
  },
  {
    "id": 313,
    "question": "不会导致出血性疾病发生的是",
    "options": ["A.高凝状态", "B.血小板及血管壁异常", "C.凝血因子功能异常", "D.病理性抗凝物质增加", "E.机体纤溶活性亢进"],
    "answer": "A"
  },
  {
    "id": 314,
    "question": "延迟性出血,APTT延长,PT正常,首先考虑异常的是",
    "options": ["A.FVII", "B.FIX", "C.FXI", "D.FXI", "E.FXII"],
    "answer": "E"
  },
  {
    "id": 315,
    "question": "关于过敏性紫癜的叙述,错误的是",
    "options": ["A.毛细血管变态反应性出血性疾病", "B.表现为皮肤、黏膜出血", "C.管壁脆性和通透性增加", "D.根据体征分5型", "E.实验室检查缺乏特异性"],
    "answer": "D"
  },
  {
    "id": 316,
    "question": "关于ITP实验室检查特点的叙述,错误的是",
    "options": ["A.外周血小板减少", "B.板形态和功能可异常", "C.巨核系增生伴成熟障碍", "D.产板型巨核细胞代偿性增生", "E.血清TPO水平无明显升高"],
    "answer": "D"
  },
  {
    "id": 317,
    "question": "关于ITP临床特点的叙述,错误的是",
    "options": ["A.急性型前有感染史", "B.急性型多见于儿童", "C.临床表现以皮肤出血为主", "D.患者脾不大或稍大", "E.机制与抗体和巨噬细胞有关"],
    "answer": "B"
  },
  {
    "id": 318,
    "question": "关于血栓性血小板减少性紫癜的“五联征”叙述错误的是",
    "options": ["A.溶血性贫血", "B.肾功能损害", "C.发热", "D.黄疸", "E.神经精神症状"],
    "answer": "D"
  },
  {
    "id": 319,
    "question": "血栓性血小板减少性紫癜的“三联征”是指",
    "options": ["A.血小板减少、溶血贫、精神症状", "B.发热、血小板减少、肾损害", "C.发热、黄疸、精神症状", "D.黄疸、血小板减少、肾损害", "E.黄疸、肾损害、精神症状"],
    "answer": "A"
  },
  {
    "id": 320,
    "question": "关于TTP实验室检查特点的叙述,错误的是",
    "options": ["A.血小板数减少", "B.多见红细胞碎片、有核红细胞", "C.血管性血友病因子减少", "D.活检见微血管内透明血栓", "E.vWF裂解酶异常"],
    "answer": "C"
  },
  {
    "id": 321,
    "question": "关于遗传性血小板功能异常性疾病的叙述,错误的是",
    "options": ["A.许兰-亨诺综合征", "B.血小板无力症", "C.巨血小板综合征", "D.贮藏池病", "E.血小板第3因子缺乏症"],
    "answer": "A"
  },
  {
    "id": 322,
    "question": "血小板无力症的发生,是由于缺陷",
    "options": ["A.GP IIb/IIIa", "B.vWF", "C.PMP", "D.PF3", "E.vWF-CP"],
    "answer": "A"
  },
  {
    "id": 323,
    "question": "巨血小板综合征的发生,是由于",
    "options": ["A.致密颗粒缺陷", "B.血小板结构异常", "C.凝血异常", "D.vWF-CP 缺陷", "E.GP Ib/IX或GPV异常"],
    "answer": "E"
  },
  {
    "id": 324,
    "question": "血小板第3因子缺乏症时,缺乏受体的凝血因子是",
    "options": ["A.FVIII和FIXa", "B.FVa和FXa", "C.FVIII和FXa", "D.FVa和FIXa", "E.FVIII和FVa"],
    "answer": "B"
  },
  {
    "id": 325,
    "question": "血友病实验室检查中,最重要的是",
    "options": ["A.APTT", "B.PT", "C.因子活性检测和抗原含量检测", "D.TT", "E.APTT 纠正试验"],
    "answer": "C"
  },
  {
    "id": 326,
    "question": "最容易发生关节畸形与残疾的是",
    "options": ["A.过敏性紫癜", "B.TTP", "C.血管性血友病", "D.血友病", "E.血小板无力症"],
    "answer": "D"
  },
  {
    "id": 327,
    "question": "血友病A初诊患者FVIII:C活性为6.5%,属于",
    "options": ["A.亚临床型", "B.轻型", "C.中型", "D.重型", "E.急性型"],
    "answer": "B"
  },
  {
    "id": 328,
    "question": "对血管性血友病分型诊断有重要意义的检测是",
    "options": ["A.vWF 多聚体检测", "B.vWF:Rco 检测", "C.FVIII:C水平检测", "D.FVIII结合试验", "E.vWF的胶原结合试验"],
    "answer": "A"
  },
  {
    "id": 329,
    "question": "会导致FVIII:C活性减低的疾病是",
    "options": ["A.肝脏疾病", "B.ITP", "C.过敏性紫癜", "D.血友病B", "E.血管性血友病"],
    "answer": "E"
  },
  {
    "id": 330,
    "question": "关于肝病所致出血原因的叙述,错误的是",
    "options": ["A.因子和抗凝蛋白合成减少", "B.因子和抗凝蛋白消耗增多", "C.异常抗凝物质及FDP增多", "D.类肝素抗凝物质灭活增多", "E.板减少及功能障碍"],
    "answer": "D"
  },
  {
    "id": 331,
    "question": "关于依赖维生素K凝血因子缺乏症的诱因叙述错误的是",
    "options": ["A.吸收不良", "B.肠道灭菌", "C.珠蛋白生成障碍贫血", "D.新生儿出血", "E.口服抗凝剂"],
    "answer": "C"
  },
  {
    "id": 332,
    "question": "关于依赖维生素K凝血因子缺乏症的叙述,错误的是",
    "options": ["A.有明确病因", "B.皮肤黏膜内脏出血", "C.多个因子联合缺乏", "D.APTT、PT正常可排除", "E.PC和PS活性可减低"],
    "answer": "D"
  },
  {
    "id": 333,
    "question": "FVIII 抑制剂常见于",
    "options": ["A.肝病凝血障碍", "B.获得性血友病", "C.ITP", "D.过敏性紫癜", "E.血管性血友病"],
    "answer": "B"
  },
  {
    "id": 334,
    "question": "关于DIC的实验室特征的叙述,错误的是",
    "options": ["A.3P试验阳性", "B.PLT升高", "C.FDP>20μg/L", "D.破碎红细胞>10%", "E.Fg<1.5g/L"],
    "answer": "B"
  },
  {
    "id": 335,
    "question": "鉴别原发纤溶和继发纤溶最佳的是",
    "options": ["A.Fg 检测和PLT 计数", "B.PT和FDP定量", "C.TT和3P试验", "D.D-二聚体和FDP 定量", "E.APTT、3P和PLT"],
    "answer": "D"
  },
  {
    "id": 336,
    "question": "关于遗传性易栓症的叙述,错误的是",
    "options": ["A.有血栓家族史", "B.多发生45岁以下", "C.血栓反复发作", "D.以微血管血栓为主", "E.难以治愈"],
    "answer": "D"
  },
  {
    "id": 337,
    "question": "关于深静脉血栓形成的原因的叙述,错误的是",
    "options": ["A.血管壁弹性", "B.静脉血流淤滞", "C.静脉壁损伤", "D.血液凝固性增高", "E.血液黏度增高"],
    "answer": "A"
  },
  {
    "id": 338,
    "question": "临床进行体外循环过程中,活化凝血时间(ACT)一般应维持在",
    "options": ["A.200~300 s", "B.300~400 s", "C.400~500 s", "D.500~600 s", "E.700~800 s"],
    "answer": "B"
  },
  {
    "id": 339,
    "question": "会导致血小板数量减少的药物是",
    "options": ["A.普通肝素", "B.阿司匹林", "C.华法林", "D.链激酶", "E.尿激酶"],
    "answer": "A"
  },
  {
    "id": 340,
    "question": "溶栓治疗监测的常用检测项目组合是",
    "options": ["A.PT、APTT、TT", "B.APTT、3P、Fg", "C.APTT、FDP、PT", "D.PLT、3P、D-二聚体", "E.Fg、TT、FDP或D-二聚体"],
    "answer": "E"
  }
]